Stochter | Your Place for Smart Finance News, Investing Tips & Community

Latest

Progress Software Stock Falls 3% Despite Higher Earnings and Raised Revenue Outlook Progress Software shares fell 3% after the company

Progress Software shares fell 3% after the company reported fiscal third-quarter results showing modest recurring revenue growth and lower overall revenue, despite stronger earnings...

09-30-26

Micron Stock Rises around 1% After Record Q4 Revenue and Strong Fiscal 2027 Guidance Micron shares rose around 1% after

Micron shares rose around 1% after the company reported record fiscal fourth-quarter results, driven by strong memory pricing, AI-related data center demand and sharp...

09-30-26

Phillips 66 Stock Rises 2.9% as Goldman Sachs and TD Cowen Raise Price Targets Phillips 66 shares rose 2.9% after

Phillips 66 shares rose 2.9% after two firms raised their price targets on the refining and energy company. Goldman Sachs increased its target to...

09-30-26

Moderna Stock Falls 6.3% as Citi Downgrades Shares to Sell Moderna shares fell 6.3% after Citigroup downgraded the biotechnology company

Moderna shares fell 6.3% after Citigroup downgraded the biotechnology company to Sell from Neutral while raising its price target to $80 from $60. Despite...

09-30-26

FormFactor Stock Jumps 8.3% as Deutsche Bank Initiates Coverage With Buy Rating FormFactor shares jumped 8.3% after Deutsche Bank initiated

FormFactor shares jumped 8.3% after Deutsche Bank initiated coverage of the semiconductor test and measurement company with a Buy rating and a $200 price...

09-30-26

Equifax Stock Falls 2.1% as BMO Capital Cuts Price Target to $160 Equifax shares fell 2.1% after BMO Capital Markets

Equifax shares fell 2.1% after BMO Capital Markets lowered its price target on the credit-reporting company to $160 from $179 while maintaining a Market...

09-30-26

The Hartford Names A. Morris Tooker as Next CEO The Hartford announced that company President A. Morris “Mo” Tooker will

The Hartford announced that company President A. Morris “Mo” Tooker will become chief executive officer, effective March 1, 2027. Tooker will succeed Christopher Swift,...

09-30-26

Servier Adopts Veeva OpenData Across More Than 80 Countries to Support AI Expansion Veeva Systems announced that French pharmaceutical company

Veeva Systems announced that French pharmaceutical company Servier is standardizing customer reference data across more than 80 countries using Veeva OpenData, creating a unified...

09-30-26

General Mills Names Dana McNabb as CEO Effective January 2027 General Mills announced that its board has unanimously elected Chief

General Mills announced that its board has unanimously elected Chief Operating Officer Dana McNabb to become chief executive officer, effective January 1, 2027. McNabb...

09-30-26

Kenvue Highlights New Neutrogena, Aveeno and Regaine Research at EADV 2026 Kenvue announced that its Neutrogena, Aveeno and Regaine brands

Kenvue announced that its Neutrogena, Aveeno and Regaine brands will present 12 new scientific data sets at the 2026 European Academy of Dermatology and...

09-30-26

FIS to Modernize Kredittbanken’s Core Platform With PRIME in the Cloud FIS announced that Norwegian consumer credit institution Kredittbanken has

FIS announced that Norwegian consumer credit institution Kredittbanken has selected FIS Total Issuing PRIME in the Cloud to modernize the core platform supporting its...

09-30-26

Trane Technologies Demonstrates 800-Volt DC Chiller for AI Data Centers Trane Technologies said it successfully demonstrated what it describes as

Trane Technologies said it successfully demonstrated what it describes as the industry’s first 800-volt direct current cooling architecture for next-generation AI factories and gigawatt-scale...

09-30-26

Germany

German Inflation Accelerates to 3.3% in September, Above Expectations

Germany’s preliminary consumer price index rose 0.6% month over month in September, above the 0.5% increase expected by economists and up from 0.2% in August.

On an annual basis, inflation accelerated to 3.3%, exceeding the 3.1% consensus and rising from 2.9% previously.

The stronger-than-expected readings suggest inflation pressures in Germany remained persistent heading into the fourth quarter, with both monthly and annual price growth moving higher.

For markets, the data are hawkish for the European Central Bank. A hotter German inflation print could reduce expectations for near-term policy easing and put upward pressure on euro-area bond yields, while providing some support to the euro.

💬

WS News 09-30-26

German Unemployment Holds at 6.4% as Jobless Total Rises More Than Expected

Germany’s unemployment rate remained at 6.4% in September, matching both market expectations and the previous month’s reading.

The number of unemployed people, however, increased by 12,000, well above the 1,000 rise expected by economists and accelerating from a 5,000 increase previously.

The data suggest that Germany’s labor market remains under some pressure even though the headline unemployment rate has not moved higher. The larger-than-expected increase in joblessness points to softer hiring conditions and weaker labor demand.

Separately, Germany’s 10-year Bund auction cleared at a yield of 3.58%, up from 3.39% previously, reflecting a higher sovereign borrowing-cost environment.

For markets, the combination of softer labor data and higher bond yields is mixed: the employment figures point to weaker economic momentum, while the rise in Bund yields may reflect broader inflation, rate or supply concerns in European fixed-income markets.

💬

WS News 09-30-26

German Retail Sales Rebound 1.3% in August, but Miss Expectations

German retail sales rose 1.3% month over month in August, rebounding sharply from a revised 3.2% decline in the previous month.

The increase, however, came in below the 1.6% gain expected by economists, indicating that the recovery in consumer spending was slightly weaker than anticipated.

💬

WS News 09-30-26

German Consumer Confidence Falls Sharply Ahead of October

Germany’s GfK Consumer Climate index fell to -30.6 for October, significantly weaker than the -27.1 expected by economists and below the previous reading of -26.8.

💬

WS News 09-25-26

German Business Sentiment Improves in September as Ifo Index Beats Expectations

Germany’s Ifo Business Climate Index rose to 89.9 in September from 88.8, coming in above the 89.1 consensus estimate and pointing to a modest improvement in business sentiment.

The current assessment index increased to 89.5 from 88.5, also beating expectations of 89.0. More notably, business expectations climbed to 90.4 from 89.0, above the 89.3 forecast.

The data suggest German companies became more confident about both present conditions and the months ahead. The stronger expectations component is particularly encouraging, as it indicates businesses see some improvement in the economic outlook despite still-soft overall activity.

For markets, the figures provide a modestly positive signal for the euro-area growth picture and may ease concerns about deeper weakness in Europe’s largest economy.

💬

WS News 09-24-26

Eurozone Growth Momentum Strengthens in September as Services Lead

Eurozone business activity improved more than expected in September, led by stronger services growth across the region.

The Eurozone Composite PMI rose to 53.1 from 52.0, beating the 51.7 consensus and signaling a faster pace of overall private-sector expansion. Services PMI increased to 53.0 from 51.6, also well above the 51.4 forecast, while manufacturing PMI held at 52.7, slightly above expectations of 52.6.

Germany showed a similar pattern. Manufacturing PMI eased to 53.8 from 54.3 and missed the 54.1 forecast, but services PMI jumped to 52.9 from 49.7, comfortably above the 49.9 consensus and returning to expansion territory.

France also improved on the services side. Services PMI climbed to 51.4 from 48.0, sharply above the 48.3 forecast, while manufacturing PMI slipped to 50.3 from 51.1 and came in below expectations.

Overall, the data suggest Eurozone growth momentum strengthened in September, with services more than offsetting some moderation in manufacturing. The stronger composite reading points to a more resilient regional economy heading into the final quarter.

💬

WS News 09-23-26

German Producer Prices Rise 1.1% in August, Beating Forecast

German producer prices increased 1.1% month over month in August, exceeding the 0.6% market forecast and matching the previous month’s pace.

The stronger-than-expected reading suggests cost pressures at the producer level remained elevated, even as broader inflation trends across Europe have shown signs of moderation.

💬

European Investor 09-18-26

Eurozone Inflation Rises to 3.2% in August as Core CPI Eases

Eurozone annual inflation accelerated to 3.2% in August from 2.9% previously, though the reading came slightly below the 3.3% market forecast.

Core inflation, which excludes more volatile components, eased to 2.4% year over year from 2.5% and matched expectations. The decline suggests underlying price pressures moderated slightly even as headline inflation moved higher.

On a monthly basis, consumer prices rose 0.4% in August, up from a 0.2% increase in the previous month.

The mixed inflation picture leaves the European Central Bank facing competing signals: headline inflation has moved further above its 2% target, while core inflation continues to cool gradually. The data could reinforce a cautious approach to further monetary-policy changes as officials assess whether the latest increase in headline prices proves persistent.

💬

WS News 09-17-26

Eurozone Industrial Production Falls 0.1% in July, Slightly Better Than Expected

Eurozone industrial production declined 0.1% month over month in July, slightly outperforming market expectations for a 0.2% contraction.

The reading was unchanged from the previous month’s 0.1% decline, indicating that industrial activity remained subdued at the start of the third quarter.

While the smaller-than-expected drop offers some relief, the continued contraction suggests the euro-area manufacturing sector is still struggling to build meaningful momentum amid weak demand and broader economic uncertainty.

💬

European Investor 09-16-26

Eurozone Trade Surplus Jumps in July as Investor Sentiment Weakens

Eurozone economic data sent mixed signals on Tuesday, with the trade balance strengthening sharply while investor confidence deteriorated.

The trade surplus widened to €14.2 billion in July, well above the €3.7 billion forecast and up from €7.2 billion previously.

However, the Eurozone ZEW Economic Sentiment Index fell to 25.8 in September from 31.4, significantly below the 39.2 expected.

Overall, stronger trade provides a positive signal for economic activity, but deteriorating expectations suggest investors remain cautious about the Eurozone outlook.

💬

The Investor 09-15-26

09-04-26WS Investor

01-27-26European Investor

11-21-25WS News

07-25-25WS Investor

07-21-25WS News

US

U.S. Crude Inventories Rise as Atlanta Fed GDPNow Estimate Drops to 3.7%

U.S. crude oil inventories increased by 922,000 barrels in the latest weekly report, contrary to expectations for a 700,000-barrel decline. The previous reading showed a much larger 2.969 million-barrel build.

Inventories at Cushing, Oklahoma, also rose by 553,000 barrels after increasing by 2.266 million barrels previously, adding to signs of a looser near-term crude supply balance.

Separately, the Atlanta Fed’s GDPNow estimate for third-quarter U.S. economic growth fell sharply to 3.7% from 5.0%. The previous estimate had also stood at 5.0%.

For markets, the inventory build is a negative signal for crude prices because it suggests supply exceeded expectations during the week. At the same time, the lower GDPNow estimate points to softer expected economic growth, which could further weigh on oil demand expectations while supporting expectations for a less restrictive Federal Reserve stance.

💬

Global Finance News 09-30-26

U.S. Stocks Rise as Softer PCE Inflation Offsets Stronger Growth and Jobs Data

U.S. stocks moved higher on Wednesday as investors welcomed softer-than-expected inflation readings alongside signs that the economy remains resilient. The S&P 500 rose 0.52%, the Dow Jones was nearly flat with a 0.03% gain, while the Nasdaq climbed 0.94%, leading the major indexes.

The August PCE price index rose 3.4% year over year, below the 3.7% expected, while monthly inflation came in at 0.3% versus the 0.4% consensus. Core PCE was also softer than forecast, rising 3.0% annually compared with expectations of 3.3%, while the monthly increase of 0.2% was below the 0.3% estimate.

At the same time, economic activity remained firm. Second-quarter GDP growth was revised to 2.2%, above the 1.5% consensus and the previous 2.1% estimate. ADP private payrolls increased by 90,000 in September, beating expectations of 73,000 and accelerating sharply from 36,000 previously.

Manufacturing activity provided another upside surprise, with the Chicago PMI jumping to 58.8 in September from 47.1, well above the 51.2 forecast and moving firmly into expansion territory.

The market reaction reflects a favorable combination for equities: inflation came in cooler than feared while employment, GDP and business activity remained relatively strong. The softer PCE readings appear particularly supportive for technology and other growth stocks, helping explain the Nasdaq’s outperformance despite the stronger economic data.

💬

WS News 09-30-26

U.S. Stocks Mixed as Consumer Confidence Slumps and Job Openings Fall

U.S. stocks were mixed on Tuesday as fresh economic data pointed to softer consumer sentiment and a cooling labor market, while technology shares showed relative resilience.

The S&P 500 was little changed at 7,682.43, the Dow Jones Industrial Average fell 0.29% to 51,334.39, and the Nasdaq rose 0.18% to 26,867.67.

The biggest negative surprise came from consumer confidence. The Conference Board’s September index fell to 81.9 from 88.6, well below the 89.2 consensus estimate. The sharp drop suggests households are becoming more cautious about the economic outlook.

Labor-market data also softened. JOLTS job openings declined to 7.079 million in August from 7.335 million and missed expectations for 7.230 million, adding to signs that demand for workers is gradually cooling.

Housing data were more mixed. The S&P/Case-Shiller 20-city home price index was flat month over month in July, down from a 0.4% increase previously, while annual home-price growth accelerated to 2.5% from 2.2%, above expectations.

For markets, the combination of weaker confidence and lower job openings may support expectations for easier Federal Reserve policy over time. However, persistent home-price inflation and broader concerns around elevated inflation are keeping the policy outlook complicated, which helps explain the uneven performance across major indexes.

💬

WS News 09-29-26

Dallas Fed Manufacturing Index Slips to 9.8 in September

The Dallas Fed Manufacturing Business Index eased to 9.8 in September from 11.6 previously, pointing to a modest loss of momentum in Texas manufacturing activity.

The index remained in positive territory, indicating that business conditions are still expanding overall, but the decline suggests the pace of improvement slowed during the month.

For markets, the reading adds to a mixed U.S. economic picture. Manufacturing remains resilient, but softer regional activity could help offset some of the inflation concerns created by higher oil prices and rising Treasury yields.

💬

WS News 09-28-26

U.S. Stocks Fall as Oil and Treasury Yields Rise, Reviving Inflation Concerns

U.S. stocks moved lower on Monday as rising oil prices pushed inflation expectations higher and drove Treasury yields back toward multi-decade highs, increasing pressure on equity valuations.

The S&P 500 fell 0.87% to 7,675.86, while the Dow Jones Industrial Average declined 0.63% to 51,503.20. The Nasdaq was the weakest of the major indexes, dropping 1.19% to 26,746.90 as higher bond yields weighed more heavily on technology and other long-duration growth stocks.

The main pressure came from energy markets. Brent crude rebounded as U.S.-Iran negotiations remained stalled and uncertainty over the Strait of Hormuz continued to threaten global supply flows. Higher oil prices are particularly important for equities because they can feed into transportation, production and consumer costs, making inflation harder to contain. (Market Screener)

Bond markets reflected those concerns. The U.S. 10-year Treasury yield climbed to about 5.26%, extending a sharp rise that has already taken yields to their highest levels in nearly two decades. Higher oil prices and stronger inflation expectations have contributed to expectations that the Federal Reserve may need to keep monetary policy tighter for longer.(FXStreet)

Inflation expectations had already been moving higher before Monday’s oil rebound. The University of Michigan’s September survey showed one-year inflation expectations rising to 4.6% from 4.0% in August, while five-year expectations edged up to 3.4% from 3.3%.

Other pressures are also weighing on sentiment. Investors are approaching a busy week of U.S. economic data, including the PCE inflation report and employment figures, while markets continue to assess the possibility of additional Federal Reserve tightening. Elevated government borrowing needs and concern over the U.S. fiscal outlook are also contributing to upward pressure on longer-term yields.

For equities, the combination is uncomfortable: higher oil prices raise inflation risks, higher inflation keeps pressure on the Fed, and higher Treasury yields increase the discount rate applied to future corporate earnings. That dynamic helps explain why the Nasdaq is underperforming the broader market in Monday trading.

💬

The Investor 09-28-26

U.S. Consumer Sentiment Improves Slightly, Inflation Expectations Stay Elevated

The University of Michigan Consumer Sentiment index rose to 48.1 in September, slightly above the 47.8 consensus estimate but down from 51.7 previously. Consumer Expectations also came in stronger than forecast at 46.3 versus 45.8 expected, although the reading remained well below the previous 51.5.

One-year inflation expectations held at 4.6%, matching expectations but rising from 4.0% previously, indicating that near-term inflation concerns remain elevated among U.S. consumers.

Separately, the Atlanta Fed’s GDPNow model estimated third-quarter U.S. economic growth at an annualized 5.0%, slightly below both the 5.1% forecast and the previous estimate. Overall, the figures show modestly better-than-expected consumer sentiment alongside persistent inflation concerns and still-strong projected economic growth.

💬

Global Finance News 09-25-26

U.S. Durable Goods Orders Hold Flat in August, Core Orders Miss Expectations

U.S. durable goods orders were unchanged in August, beating expectations for a 0.3% decline but slowing sharply from the previous month’s 0.9% increase.

Core durable goods orders, which exclude transportation, rose 0.3% month over month, below the 0.6% consensus estimate and down from 0.7% previously.

💬

WS News 09-25-26

U.S. 7-Year Treasury Auction Yield Jumps to 5.085%

The U.S. Treasury’s latest 7-year note auction cleared at a yield of 5.085%, sharply above the previous auction’s 4.512%.

The roughly 57-basis-point increase signals a materially higher yield environment for intermediate-term U.S. government debt and may reflect investors demanding greater compensation amid persistent inflation, resilient economic data and uncertainty over the Federal Reserve’s rate path.

💬

WS Investor 09-24-26

U.S. Stocks Edge Lower as Jobless Claims Stay Low and Home Sales Beat Expectations

U.S. stocks traded modestly lower on Thursday, with the S&P 500 down 0.18% at 7,692.30, the Dow Jones falling 0.25% to 51,381.27 and the Nasdaq declining 0.53% to 26,792.15.

Fresh economic data pointed to continued resilience in parts of the U.S. economy. Initial jobless claims came in at 197,000, below the 201,000 expected and slightly below the previous 198,000, suggesting layoffs remain relatively contained. Continuing claims were 1.719 million, also below the 1.750 million forecast.

Housing data were also stronger than expected. August building permits were revised to 1.403 million from an earlier 1.394 million estimate, while new home sales reached 684,000, well above the 615,000 consensus and up from 643,000 previously.

The relatively firm labor and housing figures may be limiting expectations for faster Federal Reserve easing, putting some pressure on equities and particularly rate-sensitive technology shares. The Nasdaq was the weakest of the three major indexes in early trading.

💬

European Investor 09-24-26

10-year Treasury yield hits highest level since 2007 as market prices in another Fed rate hike

The 10-year Treasury yield rose to its highest level since 2007 on Wednesday.

(finance.yahoo.com)

💬

WS News 09-23-26

09-30-26WS News

09-28-26European Investor

09-24-26WS News

NASDAQ:MU

Micron Stock Rises around 1% After Record Q4 Revenue and Strong Fiscal 2027 Guidance

Micron shares rose around 1% after the company reported record fiscal fourth-quarter results, driven by strong memory pricing, AI-related data center demand and sharp growth across both DRAM and NAND.

Fourth-quarter revenue reached $54.2 billion, up 31% sequentially and 379% year over year. Full-year revenue climbed 256% to $133.2 billion. Non-GAAP gross margin reached 87%, while operating income was $44.6 billion and diluted EPS came in at $33.42.

DRAM generated $39.8 billion in quarterly revenue, representing 73% of total sales and rising 27% sequentially. NAND revenue increased 42% to $14.1 billion, supported by roughly 30% sequential growth in average selling prices.

Data center businesses remained key growth drivers. Cloud Memory revenue reached a record $16.3 billion, while Core Data Center revenue hit $18.0 billion, up 56% sequentially. Core Data Center gross margin increased to 90%.

Cash generation was also exceptionally strong, with $44.0 billion in operating cash flow and $33.2 billion in adjusted free cash flow during the quarter.

For fiscal Q1 2027, Micron expects revenue of $61.5 billion, plus or minus $1.5 billion, non-GAAP gross margin of approximately 86.25% and diluted EPS of $38.15, plus or minus $1.00.

The 1% gain suggests investors welcomed another record quarter and strong guidance, although the relatively modest reaction may indicate that exceptionally strong memory pricing and AI-related growth expectations were already reflected in the stock.

💬

The Investor 09-30-26

Micron Unveils World’s First 512GB DDR5 Server Memory Module for AI Workloads

Micron Technology (NASDAQ: MU) announced the successful demonstration of what it calls the world’s first 512GB DDR5 RDIMM, targeting next-generation AI, cloud and data-intensive server workloads. Micron shares were up about 0.9% at $932.40 at the time of the announcement.

The new module delivers speeds of up to 9,200 MT/s and can enable as much as 12TB of DDR5 memory in a 24-slot dual-socket server. AMD and Intel are actively validating the technology for future server platforms.

Micron said the 512GB module can reduce operating power by more than 60% compared with four 128GB modules while delivering up to 1.4 times higher performance in certain memory-bound workloads. The technology is designed for rapidly expanding applications including large language models, agentic AI, real-time inference and high-performance databases.

Volume production is expected in the second half of 2027. The development further positions Micron to benefit from growing AI infrastructure demand as data centers require increasingly larger and more power-efficient memory capacity.

💬

The Investor 09-15-26

Micron Unveils $10 Billion U.S. Research Hub for Memory and AI

Micron Technology (NASDAQ: MU) announced plans to invest $10 billion over the next decade in Micron Research Labs, a new U.S.-based research institution focused on next-generation memory, computing and AI technologies.

The flagship research campus will be located in Boise, Idaho, with construction expected to begin in 2027. Research will focus on advanced memory technologies, memory and compute architectures, semiconductor packaging and future manufacturing technologies.

Micron Strengthens Its Position in the AI Supply Chain

The initiative will connect Micron with universities, government agencies, startups and semiconductor companies, targeting technologies beyond current product roadmaps and even beyond a 10-year research horizon.

The investment is separate from Micron's previously announced plans to spend more than $250 billion on U.S. manufacturing and R&D, which the company says could create more than 90,000 jobs.

The announcement also received support from major technology executives, including NVIDIA CEO Jensen Huang and Apple CEO Tim Cook, highlighting memory's increasingly important role in AI computing.

The investment reinforces Micron's strategic exposure to rapidly expanding AI infrastructure demand, where high-performance memory has become a critical component alongside GPUs and other accelerators.

💬

WS Investor 08-20-26

Micron Launches $250 Million AI Fund to Target Next Generation of Computing

Micron Technology (NASDAQ: MU) has launched a new $250 million venture fund focused on artificial intelligence, expanding the memory chipmaker’s investments across technologies expected to drive future demand for advanced memory and storage.

The Micron Ventures Paradigm Fund is the company’s third and largest venture fund to date. It will invest across the AI technology stack, including model architectures, compute infrastructure, enterprise applications and physical AI technologies such as robotics.

Micron Looks Beyond Current AI Boom

The strategy reflects Micron’s expectation that AI development will increasingly move beyond generative models toward systems capable of reasoning, autonomous action and interaction with the physical world.

Those changes could significantly increase requirements for high-performance memory and storage — markets where Micron is a major supplier of DRAM and NAND products.

The fund will focus on four areas: AI model architecture and data infrastructure; compute technologies including in-memory computing, networking and data-center efficiency; enterprise AI applications including semiconductor design and manufacturing; and physical AI such as robotics and emerging device formats.

By investing in startups developing these technologies, Micron also gains earlier visibility into how future AI architectures could change memory and storage requirements.

Micron Expands AI Investment Strategy

The Paradigm Fund follows Micron Ventures’ first fund launched in 2019 and its second fund launched in 2022, which remains active. Including the new vehicle, Micron Ventures’ total committed capital will rise to $550 million.

The initiative also reinforces Micron’s increasingly important position in the AI semiconductor ecosystem. Rapid expansion of AI servers and accelerators has increased demand for high-performance memory, particularly as increasingly complex models require greater memory capacity and bandwidth.

Rather than representing a direct expansion of Micron’s manufacturing capacity, the $250 million fund is a strategic investment designed to give the company exposure to technologies that could shape the next generation of AI infrastructure — and ultimately determine future demand for its memory and storage products.

💬

Global Finance News 08-14-26

Semiconductor Stocks Fall as China's Chip Breakthrough Pressures Nvidia and the AI Sector

Semiconductor stocks came under pressure on Monday, dragging the Nasdaq lower as investors weighed China's rapidly advancing semiconductor industry against the latest developments in the global AI infrastructure race. Nvidia led the sector's decline, falling more than 4%, while weakness spread across AI and memory chipmakers.

The latest catalyst on the AI front came after reports that Nvidia is in talks to provide roughly $250 billion in financing guarantees for OpenAI's massive AI data center project in Ohio. The proposed 10-gigawatt facility would rank among the world's largest AI infrastructure projects, underscoring the enormous capital being committed to artificial intelligence. While the news reinforces long-term demand for AI hardware, it also highlights the rapidly evolving competitive landscape and the unprecedented scale of investment required across the industry.

Investor sentiment was also weighed down by developments in China. ChangXin Memory Technologies (CXMT), China's largest memory chipmaker, surged more than 400% in its Shanghai trading debut following Asia's largest IPO of 2026. The emergence of another major Chinese chipmaker renewed concerns that global competition in memory and AI-related semiconductors will intensify. Those concerns were particularly significant for Nvidia, whose growth opportunities in China have already been constrained by U.S. export restrictions.

The weakness extended across the broader semiconductor sector. Memory-related companies including Sandisk, Micron Technology, Western Digital, and SK Hynix posted notable declines, while ASML, AMD, Intel, Marvell Technology, Super Micro Computer, and Taiwan Semiconductor Manufacturing Co. (TSMC) also traded lower as investors reassessed the industry's competitive outlook.

Despite Monday's selloff, the semiconductor industry's long-term fundamentals remain supported by accelerating AI adoption and record investment in data center infrastructure. However, the combination of elevated valuations, China's rapid technological progress, and an increasingly competitive global landscape prompted investors to lock in profits following the sector's strong rally.

💬

European Investor 07-27-26

Micron Technology (NASDAQ: MU) extended its rally on Thursday after a series of Wall Street firms raised their price targets following the company's record quarterly results and stronger-than-expected outlook, reinforcing confidence in the AI memory leader.

Needham, Raymond James, RBC Capital Markets, Susquehanna, KeyBanc, Goldman Sachs, and Morgan Stanley all increased their price targets, while Wolfe Research initiated coverage with a bullish target. The wave of analyst upgrades followed Micron's record fiscal third-quarter earnings and robust fourth-quarter guidance, highlighting accelerating demand for high-bandwidth memory (HBM) and AI infrastructure.

Analysts pointed to Micron's expanding strategic customer agreements, improving pricing environment, and leadership in AI-focused memory products as key drivers of long-term growth. Several firms also cited growing visibility into earnings as hyperscale cloud providers continue investing heavily in AI data centers.

Shares climbed nearly 16% as investors welcomed both the blockbuster earnings report and the broad-based analyst support, reinforcing Micron's position as one of the semiconductor sector's strongest AI beneficiaries.

💬

European Investor 06-25-26

Tech stocks live: Micron stock jumps over 12% on earnings beat after tumbling earlier this week

Wow, very good earning results for Micron

(finance.yahoo.com)

💬

The Investor 06-25-26

Micron Technology (NASDAQ: MU) surged 17% in after-hours trading after reporting record fiscal third-quarter results and issuing a significantly stronger-than-expected outlook, fueled by booming AI-driven demand for memory chips.

The company posted record quarterly revenue of $41.5 billion, up sharply from $23.9 billion in the previous quarter and $9.3 billion a year ago. Non-GAAP earnings reached $25.11 per share, while operating cash flow more than doubled sequentially to $25.4 billion, highlighting the strength of Micron's business momentum.

Management also announced multi-year Strategic Customer Agreements designed to improve revenue visibility and support long-term growth. Demand remained robust across cloud, data center, mobile, automotive, and embedded markets, with high-bandwidth memory (HBM) products continuing to benefit from rapid AI infrastructure investments.

Investors were particularly encouraged by Micron's fourth-quarter guidance. The company expects revenue of approximately $50 billion and non-GAAP EPS of about $31.00, both well above current market expectations. Management also projected gross margins of roughly 86%, underscoring continued pricing power and favorable supply-demand dynamics.

The strong earnings report reinforced Micron's position as one of the biggest beneficiaries of the AI investment cycle, driving broad optimism across the semiconductor sector in after-hours trading.

💬

The Investor 06-25-26

Micron Technology (NASDAQ: MU) and Qualcomm (NASDAQ: QCOM) fell sharply on Tuesday despite receiving higher price targets from Bank of America, as a broad selloff across semiconductor and technology stocks weighed on investor sentiment.

Micron dropped 7.9% to $1,115.82 after Bank of America raised its price target to $1,500 from $950 and maintained a Buy rating. The sizable increase reflects growing confidence in the memory chip maker's position within the AI infrastructure market, where demand for high-bandwidth memory and advanced data center products continues to expand.

Qualcomm fell 6.9% to $206.55 after Bank of America increased its price target to $195 from $165. Although the firm maintained an Underperform rating, the higher target suggests improving expectations for the company's earnings outlook and AI-related opportunities.

The declines came as investors broadly reduced exposure to semiconductor and AI-related stocks following weakness across the technology sector. The selloff overshadowed otherwise positive analyst commentary and reflected concerns about near-term demand trends and elevated valuations after a strong rally in chip stocks.

Despite Tuesday's weakness, the analyst actions indicate Wall Street remains constructive on long-term semiconductor growth, particularly as artificial intelligence continues to drive investment in advanced computing infrastructure and next-generation devices.

💬

European Investor 06-23-26

Micron Gains Premarket as Bernstein Sets $1,300 Price Target

Micron Technology (NASDAQ: MU) rose 3.3% in premarket trading after Sanford C. Bernstein initiated coverage with a $1,300 price target, highlighting continued optimism surrounding the memory chip maker's position in the rapidly expanding artificial intelligence market.

The bullish target reflects growing confidence that Micron will remain one of the primary beneficiaries of increasing demand for high-bandwidth memory (HBM) and advanced DRAM products used in AI servers and data centers. As hyperscale cloud providers and technology companies accelerate investments in AI infrastructure, demand for memory solutions has become a critical component of the semiconductor industry's growth cycle.

Micron has emerged as one of the strongest beneficiaries of the AI boom, with investors increasingly focused on the company's ability to supply memory chips required for next-generation AI accelerators and data center deployments. Industry demand has remained robust as companies continue expanding computing capacity to support large language models and AI applications.

The analyst action follows a series of recent bullish calls across the semiconductor sector, where firms have raised expectations for AI-related spending over the coming years. Investors continue to view memory as one of the most supply-constrained segments of the AI hardware ecosystem, supporting favorable pricing and profitability trends.

The stock's premarket advance suggests investors welcomed the new price target as further validation of Micron's growth outlook. With AI infrastructure spending showing few signs of slowing, the company remains well positioned to capitalize on rising demand for advanced memory technologies and data center solutions.

💬

WS Investor 06-22-26

09-30-26WS News

09-28-26European Investor

09-28-26WS News

09-23-26WS News

Gold

Gold, Silver and Bitcoin Fall as Rising Treasury Yields Pressure Alternative Assets

Gold, silver and Bitcoin moved sharply lower on Monday as rising U.S. Treasury yields and renewed inflation concerns weighed on assets that do not generate income.

Gold futures fell 3.9% to about $4,151.80 an ounce, while silver dropped 5.5% to $61.24. Bitcoin declined 1.9% to around $82,924, extending the broader risk-off move across markets.

The selloff comes as U.S. bond yields continue to climb, with the 10-year Treasury yield moving above 5.2%. Higher yields increase the opportunity cost of holding gold and silver, while also tightening financial conditions for speculative assets such as Bitcoin.

Rising oil prices are adding to the pressure by pushing inflation expectations higher. That makes investors less confident that the Federal Reserve will be able to ease monetary policy quickly and increases the possibility that interest rates remain elevated for longer.

Silver is underperforming gold because it carries both precious-metal and industrial exposure, making it more sensitive to shifts in growth expectations and market volatility. Bitcoin is also being pressured by the same higher-rate environment as investors reduce exposure to riskier assets.

The common theme across all three markets is the sharp rise in real and nominal yields. Unless Treasury yields stabilize, gold, silver and Bitcoin could remain vulnerable despite their different long-term investment narratives.

💬

The Investor 09-28-26

Gold steadies above $4,300 as oil eases and yields stay high - Kitco AM Report | Kitco News

Gold steadies above $4,300 as oil eases and ...

(kitco.com)

💬

The Investor 09-21-26

Gold and Bitcoin Rise as Investors Seek Safety and Risk Exposure After Fed Decision

Gold and Bitcoin moved higher Friday, with both assets benefiting from shifting expectations around inflation, interest rates and broader market risk sentiment.

December gold futures rose 0.60% to about $4,426 an ounce, extending gains as investors continued to assess the Federal Reserve’s latest rate increase and the outlook for inflation. Gold remained supported by demand for defensive assets, even as oil prices retreated and some immediate geopolitical supply concerns eased.

Bitcoin climbed 2.13% to around $78,019, recovering further from recent weakness. The cryptocurrency moved steadily higher through the session and briefly approached $78,500 as risk appetite improved.

The moves reflect different parts of the same macro environment. Gold is benefiting from continued demand for inflation protection and safe-haven exposure, while Bitcoin is drawing support from stronger appetite for higher-risk assets and renewed interest in crypto after the Fed’s policy decision reduced some uncertainty around the near-term rate outlook.

For both markets, the next major drivers are likely to be U.S. inflation data, Treasury yields, the dollar and any further signals from Federal Reserve officials about the possibility of additional rate increases.

💬

European Investor 09-18-26

Gold price holding near session highs as US pending home sales rise 0.3% | Kitco News

Gold price holding near session highs as ...

(kitco.com)

💬

The Investor 09-17-26

Gold Rises Nearly 1% as Treasury Yields and Dollar Ease Ahead of Fed Decision

Gold prices moved higher Wednesday, with December futures rising 0.98% to around $4,375 an ounce, recovering after recent pressure as investors prepared for the Federal Reserve’s interest-rate decision later in the day.

The rebound was supported by a pullback in U.S. Treasury yields and a softer dollar. The 10-year Treasury yield had climbed above 5% on Tuesday, its highest level since 2007, before easing Wednesday. Lower yields improve the relative appeal of non-yielding assets such as gold and bitcoin.

Oil prices also retreated after their recent surge, easing some concerns that higher energy costs could intensify inflation. Markets nevertheless continue to expect the Fed to raise rates by 25 basis points, making the central bank’s guidance on the path of future rates particularly important for gold.

Geopolitical uncertainty in the Middle East continues to provide some safe-haven support. For gold, the immediate focus is now on whether the Fed’s message pushes Treasury yields and the dollar higher again.

💬

European Investor 09-16-26

Gold Slides as Treasury Yields Surge, While Oil Rally Fuels Fed Rate-Hike Bets

Gold prices fell sharply on Tuesday as surging U.S. Treasury yields and growing expectations for a Federal Reserve rate hike outweighed safe-haven demand generated by geopolitical tensions.

December gold futures dropped 1.13% to around $4,302.60 an ounce. The benchmark 10-year U.S. Treasury yield climbed above 5%, reaching its highest level since 2007, increasing the opportunity cost of holding non-yielding gold.

Oil prices are adding to the pressure. Brent crude remained above $100 a barrel, futures up 1.76% at $102.77. Escalating Middle East tensions and risks to energy infrastructure have intensified concerns that elevated oil prices could keep inflation persistent.

Those concerns have dramatically shifted expectations for this week’s Fed meeting. Markets are now pricing roughly a 90% probability of a 25-basis-point rate increase, compared with much lower expectations before the latest inflation and energy-price developments.

The combination of higher oil prices, rising Treasury yields and increasingly hawkish Fed expectations is currently overpowering gold’s traditional geopolitical safe-haven support. Investors will now focus on Wednesday’s Fed decision and, particularly, signals about whether further rate increases could follow.

💬

Global Finance News 09-15-26

The next trillion matters more for gold than the next Fed rate hike | Kitco News

The next trillion matters more for gold than the next Fed rate hike
...

(kitco.com)

💬

The Investor 09-12-26

Gold and Bitcoin End Volatile Week Lower as Fed Rate-Hike Expectations Rise

Gold and Bitcoin came under pressure this week as surging Treasury yields, persistent U.S. inflation and sharply higher oil prices strengthened expectations that the Federal Reserve could raise interest rates at its September meeting.

Gold December futures finished Friday at $4,408.90 per ounce, nearly unchanged on the day but down about 1.8% over five sessions. Spot gold lost roughly 1.5% for the week, marking a third consecutive weekly decline. Rising bond yields were the main headwind, with the U.S. 10-year Treasury yield approaching 5% as investors repriced the interest-rate outlook. (Reuters)

Inflation remained central to the selloff. August CPI rose 0.4% month over month and 3.4% annually, while core prices increased 0.3%. Markets ended the week pricing an approximately 87% probability of a Fed rate increase next week. Gold nevertheless attracted dip-buying on Friday, while geopolitical uncertainty continued to provide some safe-haven support. (Reuters)

Bitcoin followed a similar risk-off pattern, falling about 2.3% over five days to around $77,300. The cryptocurrency briefly approached $80,000 before retreating toward $77,000 as higher yields reduced investor appetite for non-yielding and higher-risk assets.

Oil added another layer of pressure. Brent gained more than 8% for the week despite retreating Friday to $104.61, as Middle East supply disruptions kept inflation concerns elevated.

Next week’s Federal Reserve decision is therefore the key catalyst for both assets. A rate hike accompanied by a hawkish outlook could keep gold and Bitcoin under pressure, while a less aggressive Fed message and a retreat in Treasury yields could provide room for a rebound.

💬

The Investor 09-12-26

Gold, Silver and Bitcoin Fall as Higher Yields Keep Pressure on Alternative Assets

Gold, silver and Bitcoin traded lower Friday as elevated Treasury yields and persistent uncertainty over the Federal Reserve’s interest-rate outlook continued to weigh on non-yielding and risk-sensitive assets.

December gold futures fell 0.51% to $4,384.70 an ounce, although prices recovered substantially from an intraday low near $4,350. December silver declined 0.66% to $64.50 an ounce after also rebounding from earlier losses.

Bitcoin was down 1.04% over the past 24 hours at around $77,151. The cryptocurrency briefly fell toward $76,500 before recovering, but remained well below the $78,000 area seen earlier in the period.

The moves come after Thursday’s stronger-than-expected U.S. producer inflation data pushed Treasury yields sharply higher and revived concerns that the Fed could maintain a tighter policy stance. Meanwhile, oil prices remain above $100 a barrel despite Friday’s pullback, keeping energy-driven inflation risks in focus.

Investors are now turning their attention to Friday’s U.S. consumer inflation data, which could provide the next major signal for Treasury yields, the dollar, precious metals and Bitcoin ahead of next week’s Federal Reserve meeting.

💬

European Investor 09-11-26

Gold, Silver and Bitcoin Slide as Surging Treasury Yields Trigger Broad Selloff

Gold, silver and Bitcoin fell sharply Thursday as rising U.S. Treasury yields and renewed inflation concerns pressured both precious metals and cryptocurrencies.

December gold futures dropped 1.23% to $4,405.70 an ounce, while December silver futures plunged 4.98% to $65.23. Bitcoin fell 2.71% over 24 hours to around $77,016, briefly approaching $76,700.

The selloff came as the benchmark 10-year U.S. Treasury yield surged to around 4.92%, its highest level since late 2023. Higher yields increase the opportunity cost of holding non-yielding assets such as gold and silver and can also tighten financial conditions for risk assets including Bitcoin.

Inflation concerns intensified after August U.S. producer prices rose 0.4% month over month and 5.4% year over year, slightly above the 5.3% annual forecast. At the same time, Brent crude surged above $104 a barrel as supply disruptions and a sharp decline in Saudi production heightened fears that energy costs could keep inflation elevated.

Silver significantly underperformed gold, reflecting its greater volatility and sensitivity to both investment flows and industrial demand. Bitcoin also came under pressure as higher bond yields reduced investors’ appetite for risk.

Markets now turn to Friday’s U.S. CPI report. Another strong inflation reading could reinforce expectations for tighter Federal Reserve policy and keep upward pressure on Treasury yields, creating further headwinds for precious metals and cryptocurrencies.

💬

WS News 09-10-26

09-30-26WS News

09-28-26European Investor

09-23-26WS News

09-17-26WS News

NYSE:JPM

Ford, JPMorganChase and Michigan Launch $2 Billion Industrial Growth Initiative

Ford Motor Company, JPMorganChase, the State of Michigan, Michigan Central and Newlab have launched Michigan LIFT, a public-private initiative designed to accelerate manufacturing innovation, strengthen domestic supply chains and help emerging suppliers scale production.

Ford plans to serve as the anchor industrial buyer and aspires to award up to $1 billion in contracts to participating suppliers over the next decade. JPMorganChase, meanwhile, aims to provide up to $1 billion in debt financing through the platform as part of its broader Security and Resiliency Initiative. :chatgpt-content-reference{index="0"}

Michigan LIFT will match manufacturing and supply-chain challenges identified by industrial buyers with suppliers capable of addressing them. Companies that advance through the program may receive support involving customer demand, financing, state resources, workforce development and commercialization services.

Initial focus areas include robotics and advanced manufacturing automation, semiconductors, batteries and advanced energy, aerospace and mobility, critical minerals and life sciences manufacturing.

Michigan Central will provide testing and scaling infrastructure, while Newlab plans to contribute $20 million in in-kind support. The partners also aim to attract 10 to 20 additional industrial buyers representing more than $1 billion in annual demand by 2036.

The initiative is designed to address a common problem for industrial startups and suppliers: promising technologies often struggle to reach commercial scale because customer demand, financing, workforce availability and qualification processes are not aligned. Michigan LIFT seeks to bring those pieces together within a single manufacturing ecosystem.

💬

WS Investor 09-29-26

Microsoft Corp. on Tuesday announced that its board of directors declared a quarterly dividend of $0.98 per share, reflecting a 7 cent or 8% increase over the previous quarter’s dividend. The dividend is payable Dec. 10, 2026, to shareholders of record on Nov. 19, 2026. The ex-dividend date will be Nov. 19, 2026.

The Board of Directors of JPMorgan Chase & Co. (NYSE: JPM) declared a quarterly dividend of $1.65 per share on the outstanding shares of the common stock of JPMorganChase, an increase from the prior quarterly dividend of $1.50 per share. The dividend is payable on October 31, 2026, to stockholders of record at the close of business on October 6, 2026.

💬

WS Investor 09-16-26

JPMorgan (JPM) Stock Rises as Strong Investment Banking and Trading Drive Record Second-Quarter Results

JPMorgan Chase (NYSE: JPM) shares gained 1.2% on Tuesday after the banking giant reported better-than-expected second-quarter results, supported by record revenue across its businesses and exceptionally strong performance in investment banking and trading.

The bank posted reported net income of $21.2 billion, or $7.70 per share, including significant gains from Visa shares and certain equity investments. Excluding those items, net income totaled $16.9 billion, or $6.14 per share. Reported revenue reached $57.3 billion, while managed revenue came in at a record $58.0 billion.

Performance was strong across all major business segments. Investment banking fees surged 30% year over year to their highest level since 2021, driven by increased deal activity and capital markets issuance. Markets revenue jumped 35%, with equity trading soaring 86% amid elevated client activity and strong financing demand, while fixed-income trading rose 6%.

The consumer business also remained resilient. Average loans increased 10% from a year earlier, deposits rose 7%, and debit and credit card spending climbed 10%. Meanwhile, assets under management reached a record $5.1 trillion, up 18% year over year, supported by $50 billion in long-term net inflows.

Chairman and CEO Jamie Dimon said the U.S. economy has remained resilient thanks to stronger business investment, AI-driven capital spending, fiscal stimulus, and regulatory improvements. However, he also warned that geopolitical conflicts, persistent inflation, large fiscal deficits, and elevated asset valuations continue to pose meaningful risks to the economic outlook.

The results reinforced JPMorgan's position as one of the strongest-performing global banks, with investors responding positively to robust capital markets activity, healthy consumer trends, and continued growth across its diversified businesses. Investors will continue watching management's outlook for investment banking activity, credit quality, and the broader macroeconomic environment in the second half of the year.

💬

The Investor 07-14-26

JPMorgan Falls Despite Truist Price Target Increase

JPMorgan Chase (NYSE: JPM) shares fell 1.8% on Friday even as Truist Financial raised its price target on the banking giant to *$344 from $332*, while maintaining a *Hold* rating.

The higher price target reflects Truist's improved outlook for JPMorgan's earnings potential and the bank's continued strength across its diversified businesses. While the firm acknowledged JPMorgan's solid fundamentals and industry-leading franchise, it kept its neutral rating, suggesting much of the upside may already be reflected in the stock's valuation.

Despite the positive target revision, JPMorgan ended Friday lower as selling pressure weighed on the broader financial sector. Nevertheless, the increased price target signals that analysts remain constructive on the bank's long-term outlook and earnings resilience.

💬

The Investor 06-27-26

JPMorgan Chase & Co. declared dividends on its Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series CC.

The bank announced a dividend of $159.02 per preferred share, equivalent to $15.9020 per depositary share. The payment will be made on May 1, 2026, to shareholders of record as of April 1, 2026.

Dividends for the Series CC preferred stock have been calculated under the floating-rate period that began on November 1, 2022.

💬

European Investor 03-14-26

Apple announced that JPMorgan Chase will become the new issuer of Apple Card, replacing the current issuing bank, with the transition expected to take place over approximately 24 months.

Apple said Apple Card users will continue to receive the same benefits during and after the transition, including up to 3% unlimited Daily Cash back, integrated spending and budgeting tools in Apple Wallet, Apple Card Family features, and access to a high-yield savings account. Mastercard will remain the payment network, ensuring continued global acceptance and existing card benefits.

The companies said the partnership reflects a shared focus on innovation, customer experience, and consumer financial health. Apple emphasized that there will be no immediate changes for users, who can continue using their Apple Card as usual while additional details will be communicated closer to the transition date.

💬

WS Investor 01-08-26

JP Morgan 3Q results

💬

WS News 10-14-25

Earnings season is here …

💬

WS News 10-12-25

JPMorgan Chase Closes $4 Billion Subordinated Notes Offering

JPMorgan Chase & Co. announced the successful closing of a $4 billion public offering of Fixed-to-Floating Rate Subordinated Notes due 2036.

The offering was made under an existing shelf registration and includes legal opinions filed as part of the company’s SEC Form 8-K submission. The notes will support the bank’s capital and funding strategy.

💬

The Investor 07-24-25

JPMorgan Chase & Co. Q2 2025 Earnings Summary

JPMorgan Chase reported Q2 2025 net income of $15.0 billion ($5.24 per share), or $14.2 billion ($4.96 per share) excluding a $774 million tax benefit. Revenue was $45.7 billion (managed basis), down 10% year-over-year. Return on equity was 18%, and CET1 capital ratio stood at 15.0%.
Business Segment Highlights:
• Consumer & Community Banking (CCB):
Net income rose 23% to $5.2 billion. Revenue increased 6% to $18.8 billion, driven by higher card income and asset management fees. Card Services revenue grew 15%.
Provision for credit losses was $2.1 billion, down from $2.6 billion last year.
• Corporate & Investment Bank (CIB):
Net income increased 13% to $6.7 billion. Total revenue rose 9% to $19.5 billion.
Markets revenue jumped 15% to $8.9 billion, with both Fixed Income and Equity Markets growing 14–15%.
Investment banking fees were up 7%, supported by stronger debt and advisory activity.
• Asset & Wealth Management (AWM):
Net income increased 17% to $1.5 billion. Revenue rose 10% to $5.8 billion, reflecting higher AUM and deposit balances.
AUM reached $4.3 trillion (+18% YoY); total client assets surpassed $6.4 trillion.
• Corporate Segment:
Net income was $1.7 billion, down from $6.8 billion last year due to the absence of a $7.9 billion Visa-related gain in 2024.
Includes a $774 million tax benefit from audit resolutions and regulatory changes.

Capital & Shareholder Returns:
• Dividend: $3.9 billion ($1.40/share)
• Stock buybacks: $7.1 billion
• Book value per share: $122.51 (+10% YoY)
• Tangible book value per share: $103.40 (+11% YoY)

CEO Jamie Dimon:

Dimon highlighted solid performance across business lines, strong liquidity of $1.5 trillion, and a healthy capital position. While economic resilience continued, he cautioned about risks such as high asset prices, geopolitical tension, and fiscal deficits.

💬

WS Investor 07-15-25

09-30-26WS News

09-29-26WS News

06-30-26WS News

05-04-26Global Finance News

NYSE:BA

Boeing Stock Falls 6.2% After Jefferies Downgrade and 737 MAX Software Issue

Boeing shares fell 6.2% to $185.88 after Jefferies downgraded the stock to Neutral from Buy, while concerns around a newly reported 737 MAX software issue added further pressure.

According to The Motley Fool, citing The Wall Street Journal, Boeing identified a software glitch affecting an automated navigation function on the 737 MAX that could fail during a missed landing approach and require pilots to take manual control.

Boeing said the issue does not create a safety risk, but the FAA is reviewing the problem. Southwest Airlines and United Airlines have also reportedly told Boeing they will not accept new 737 MAX aircraft with the affected software installed.

A temporary workaround could involve reinstalling an earlier software version, while Boeing is reportedly working toward a permanent fix by early 2028.

The stock decline reflects a combination of renewed execution concerns around the 737 MAX and the Jefferies downgrade, with investors focusing on possible delivery delays, regulatory scrutiny and Boeing’s ability to stabilize production.

💬

European Investor 09-28-26

Boeing Stock Rises 2.1% as Turkish Airlines Finalizes Order for Up to 150 737 MAX Jets

Boeing shares rose 2.1% to $201.82 after the company and Turkish Airlines finalized an order for up to 150 737 MAX aircraft, marking the carrier’s largest Boeing single-aisle order.

Turkish Airlines purchased 100 737-8 jets and secured options for 50 additional 737 MAX aircraft. The agreement also includes substitution rights for the larger 737-10 variant, giving the airline flexibility as it expands its short- and medium-haul network.

The deal builds on Turkish Airlines’ 2025 order for up to 75 Boeing 787 Dreamliners and supports the carrier’s broader fleet and network expansion strategy. Boeing said the 737 MAX family can reduce fuel use and emissions by about 20% compared with the aircraft it replaces.

The order also carries strategic value for Boeing by strengthening its relationship with a major global airline and adding to commercial aircraft demand. Turkish Airlines, including AJet, already operates more than 200 Boeing aircraft across several models.

The 2.1% stock gain suggests investors viewed the finalized order as supportive of Boeing’s commercial backlog and longer-term production outlook.

💬

The Investor 09-23-26

# Boeing and American Airlines Complete First 737 MAX Landing Gear Exchange

Boeing and American Airlines completed the first landing gear exchange for a 737 MAX, marking the expansion of Boeing’s longstanding Landing Gear Exchange Program to its latest-generation single-aisle aircraft.

Under the program, Boeing supplies fully overhauled and certified main and nose landing gear assemblies that arrive ready for installation. The approach is designed to reduce aircraft-on-ground time and allow airlines to avoid purchasing and storing expensive spare landing gear.

The first exchange with American Airlines also validated the full process, including overhaul, certification, documentation and delivery. Boeing said the model can help operators shorten maintenance downtime, reduce spare-parts requirements and better align major maintenance with fleet operations.

Boeing now plans to expand global overhaul capacity and work with certified maintenance partners to increase availability. Near-term priorities include building a larger inventory of 737 MAX-compatible exchange equipment and adding forward-exchange slots closer to airline operations.

The initiative could also strengthen Boeing’s aftermarket services business as the global 737 MAX fleet expands and more aircraft move into heavier maintenance cycles.

💬

WS Investor 09-14-26

Archer Aviation to Acquire Boeing’s Wisk, Insitu and SkyGrid in Major Aerospace and Defense Deal

Archer Aviation (NYSE: ACHR) has agreed to acquire Boeing’s Wisk Aero, Insitu and SkyGrid subsidiaries in a major transaction designed to transform Archer into a broader aerospace, defense and autonomous aviation platform.

The deal combines Archer’s eVTOL aircraft, unmanned systems and ZEE AI platform with Wisk’s autonomous flight technology, Insitu’s defense-focused unmanned aircraft systems and SkyGrid’s automated airspace management software. Together, the businesses have accumulated nearly two million flight hours.

The acquisition also gives Archer an established and profitable defense operation generating more than $200 million in annual revenue, with activities spanning 35 countries. Insitu alone has manufactured and deployed more than 3,500 unmanned aircraft systems, providing Archer with a substantially larger presence in the global defense market.

Boeing to Invest in Archer

As part of the transaction, Boeing (NYSE: BA) will take an equity stake in Archer and become a strategic partner. The companies will also establish a technology-sharing arrangement, allowing Boeing to retain access to Wisk’s autonomous flight technology for future commercial and defense aircraft.

For Boeing, the transaction allows the company to concentrate capital on its core businesses while maintaining exposure to the technologies developed by Wisk, Insitu and SkyGrid through its Archer investment and partnership.

For Archer, the acquisition represents a significant diversification beyond its emerging air-taxi business. The company intends to combine autonomous flight, AI, drones, airspace management and eVTOL technologies into what it describes as an end-to-end “physical AI” platform for commercial aerospace and defense.

The transaction is expected to close by the end of 2026, subject to regulatory approvals and other customary closing conditions.

💬

Global Finance News 08-11-26

Boeing Stock Rises 3% as Improving Cash Flow and Record Backlog Outweigh Continued Losses

Boeing (NYSE: BA) shares climbed about 3% on Tuesday after the aerospace giant reported a stronger second quarter, with higher aircraft deliveries, a return to positive free cash flow, and a record backlog that reinforced confidence in the company’s recovery.

Second-quarter revenue increased 8% year over year to $24.6 billion, driven primarily by 171 commercial aircraft deliveries, up from 150 a year ago. Although Boeing remained unprofitable, its performance improved meaningfully, reporting a GAAP loss per share of $0.67 versus a loss of $0.92 last year, while core loss per share narrowed to $0.76 from $1.24. The company also generated $1.4 billion in operating cash flow and $631 million in free cash flow, marking a significant turnaround from negative free cash flow in the prior-year period.

One of the biggest positives for investors was Boeing’s record $715 billion total backlog, including more than 6,200 commercial aircraft valued at approximately $597 billion. The company booked 246 net commercial aircraft orders during the quarter, reflecting continued strong demand from airlines despite ongoing supply chain challenges.

The Commercial Airplanes division continued to show operational improvement. Revenue rose 8% to $11.8 billion, while operating losses narrowed substantially as higher deliveries, improved production performance, and a more favorable aircraft mix boosted results. Boeing also reported progress on key certification programs, completing certification flight testing for both the 737-7 and 737-10, while the 777X program advanced into FAA certification flight testing. Management continues to target certification of the 737 variants in 2026 and first deliveries in 2027.

The Defense, Space & Security segment remained a weak spot. Although revenue increased 13% to $7.5 billion, the business posted a slight operating loss after recording $280 million in additional charges related to the VC-25B presidential aircraft program. Meanwhile, Global Services delivered stable revenue but experienced modest margin compression.

Investors appeared encouraged by Boeing’s improving fundamentals rather than its remaining losses. Stronger cash generation, rising commercial deliveries, progress on certification milestones, declining debt, and a record order backlog suggest the company’s multi-year recovery is gaining momentum, helping lift the stock despite continued earnings losses.

💬

WS News 07-28-26

Boeing Secures New 737 MAX Order from Kazakhstan's SCAT Airlines

SCAT Airlines has placed a firm order for five additional Boeing 737-9 jets and converted five previously ordered 737-8s to the larger 737-9 variant, bringing its total commitment to ten of the wider aircraft. The Shymkent-based carrier, the first in Central Asia to operate the 737 MAX, plans to use the expanded fleet to grow its international network, including new long-haul and seventh-freedom routes across Europe and Asia. The 737-9 seats up to 220 passengers and offers a range of up to 6,110 kilometers, while burning 20% less fuel than the jets it replaces.

Source: PRNewswire

💬

Global Finance News 04-29-26

Boeing and the U.S. Navy have successfully completed the first test flight of the operational MQ-25A Stingray unmanned aircraft, marking a key milestone toward carrier-based deployment.

During the two-hour flight, the aircraft demonstrated full autonomous capabilities, including taxiing, takeoff, navigation, and landing, while responding to commands from a ground control station. The test validated flight controls and integration with mission systems.

The MQ-25A is designed as a carrier-based aerial refueling drone, expected to extend the operational range of the Navy’s air wing and enable manned-unmanned teaming. It will allow fighter jets such as the F/A-18 Super Hornet to focus on combat missions rather than refueling roles.

The program will now move into further testing phases before transitioning to carrier qualification trials, bringing the system closer to operational deployment.

Source: PRNewswire

💬

The Investor 04-27-26

Boeing reported first-quarter 2026 revenue of $22.2 billion, up 14% year-over-year, driven by higher commercial aircraft deliveries. The company posted a narrower loss, with a GAAP loss per share of $0.11, while operational performance improved across segments.

Boeing delivered 143 commercial aircraft during the quarter and saw its total backlog rise to a record $695 billion, including more than 6,100 airplanes. Defense and services segments also recorded growth, supported by increased volumes and new contracts.

Despite improvements, free cash flow remained negative at $1.5 billion, reflecting ongoing investments and production ramp-up. The company emphasized continued progress in certification programs and production stability as it works to strengthen long-term performance.

Source: PR Newswire

💬

Global Finance News 04-24-26

Boeing to Release First Quarter Results on April 22

💬

European Investor 03-31-26

Rheinmetall and Boeing partner to offer MQ-28 Ghost Bat for German air force

31 March 2026 — Rheinmetall AG and Boeing announced a strategic partnership to offer the MQ-28 Ghost Bat unmanned aircraft for Germany’s planned deployment of collaborative combat aircraft (CCA) by 2029.

The MQ-28, developed in Australia, is an autonomous aircraft designed to operate alongside manned fighter jets, performing missions such as reconnaissance, electronic warfare, and combat support. It has already completed over 150 test flights and is considered a mature platform for operational deployment.

Under the agreement, Rheinmetall will act as the system integrator in Germany, responsible for adapting the platform to national requirements and integrating it into the Bundeswehr’s command and weapons systems. The partnership also aims to strengthen Germany’s defence industrial base through local production and development capabilities.

The collaboration is expected to accelerate deployment timelines and enhance Germany’s military capabilities, while supporting long-term technological development and supply security.

💬

The Investor 03-31-26

09-30-26WS News

08-03-26WS News

07-20-26WS News

Brent Crude

💬

Global Finance News 09-30-26

Brent Crude Rises 1.6% as U.S.-Iran Talks Stall and Hormuz Risks Persist

Brent crude futures rose 1.6% to around $99 a barrel on Monday as geopolitical risk returned to the market following another setback in U.S.-Iran negotiations.

Oil prices gained after U.S. President Donald Trump rejected Iran’s latest proposal aimed at reopening the Strait of Hormuz, while both sides remained open to further talks. The unresolved dispute has kept a geopolitical premium in crude because the waterway remains critical to Gulf oil exports.(thenationalnews*com)

At the same time, supply concerns are being partly offset by improving regional export flows. Middle East crude exports are on track to reach about 12.8 million barrels per day in September, their highest level since the conflict began, while shipments through Hormuz have also recovered significantly from earlier disruptions.(Iran International)

Saudi Arabia’s East-West pipeline has also restarted after being damaged earlier this month, providing another route for crude exports and limiting some of the upside pressure on prices. (Reuters)

The result is a highly volatile oil market: geopolitical tensions continue to support Brent, while improving Gulf exports and alternative Saudi shipping routes are preventing supply fears from escalating further.

💬

The Investor 09-28-26

Brent Crude Climbs Back Above $100 as U.S.-Iran Tensions Revive Supply Concerns

Brent crude futures rose 2.08% to $100.16 a barrel on Thursday as renewed concerns over Middle East supply risks outweighed recent optimism around improving Gulf exports.

Oil prices rebounded after hopes for a quick U.S.-Iran diplomatic breakthrough faded. Talks surrounding the UN General Assembly produced limited progress, while uncertainty remained over the reopening of the Strait of Hormuz, a critical route for global crude shipments. (The National)

The move reverses part of Brent’s recent decline. Earlier this week, prices had fallen below $100 as Saudi Arabia restarted its East-West pipeline and markets anticipated increased exports through the Red Sea, while expectations for U.S.-Iran negotiations reduced the geopolitical risk premium. (FXStreet)

Supply concerns have not disappeared, however. Restrictions around Hormuz remain a major risk, while tight refined-product markets—particularly diesel—are adding support to crude prices. (Kitco)

Near-term direction is likely to remain highly sensitive to developments between Washington and Tehran, shipping flows through Hormuz and the pace of Saudi supply normalization.

💬

European Investor 09-24-26

Brent Crude Falls 1.1% as Saudi Pipeline Restarts and Hormuz Reopening Hopes Pressure Prices

Brent crude futures fell 1.14% to around $99.20 a barrel Tuesday, extending recent weakness as improving Middle East supply prospects reduced some of the geopolitical risk premium in oil prices.

The biggest pressure came from Saudi Arabia’s East-West Pipeline. The kingdom has restarted operations after the route was shut following drone attacks, and exports from the Red Sea port of Yanbu could resume. The pipeline had been used to reroute roughly 4 million barrels per day around the Strait of Hormuz, making its restart an important development for regional supply. (Reuters)

Oil prices also weakened after Iran signaled that the Strait of Hormuz could reopen within seven days if the U.S. eases military pressure and lifts its blockade on Iranian ports. The possibility of renewed diplomacy has reduced fears of a prolonged disruption through one of the world’s most important oil transit routes. (Reuters)

At the same time, physical supply flows appear to be adapting. Middle Eastern exporters have increasingly used alternative routes and storage hubs, while Saudi shipments have remained stronger than initially feared.

Still, downside risks are not one-sided. Shipping traffic through Hormuz remains far below pre-conflict levels, and continued regional fighting means oil could remain volatile even if supply conditions improve further.

💬

WS Investor 09-22-26

Brent Crude Falls 4% as Supply Fears Ease

Brent crude futures fell 4.01% to around $99.71 a barrel Monday, dropping back below the $100 level as traders reduced part of the geopolitical risk premium built into oil prices over the past week.

The decline reflects growing confidence that Saudi crude exports are recovering from recent disruptions and that alternative export routes are helping stabilize regional supply. Reuters reported that Saudi shipments have rebounded sharply in September, easing fears of a prolonged supply shock.

Oil was also pressured by renewed hopes for diplomatic progress involving the U.S. and Iran, which reduced some concern that Middle East tensions could escalate further and disrupt major energy routes.

Despite the pullback, geopolitical risk remains elevated. Shipping through the Strait of Hormuz is still below normal levels, and recent attacks on regional infrastructure continue to leave the market vulnerable to sudden supply disruptions.

For now, Brent’s move below $100 suggests traders are shifting their focus from worst-case supply scenarios toward improving export flows and the possibility of diplomatic de-escalation.

💬

The Investor 09-21-26

Brent Crude Falls Below $100 as Saudi Supply Concerns Ease

Brent crude futures fell 1.37% to around $98.56 a barrel Friday morning, extending a multi-session decline as fears of an immediate Saudi supply disruption continued to fade.

Oil prices had surged earlier in the week after attacks damaged Saudi Arabia’s East-West pipeline and disrupted loadings from the Yanbu export hub. Since then, Saudi Arabia has begun restoring pipeline capacity and increasing crude movements through alternative routes, including Oman, reducing some of the geopolitical risk premium that had pushed Brent toward $110. (Reuters)

Geopolitical risks remain significant in Middle East and Ukraine, however. That means oil prices could remain volatile even as immediate supply fears ease.

💬

European Investor 09-18-26

Brent Crude Falls 1.4% as Middle East Supply Fears Ease

Brent crude futures fell 1.44% to around $104.31 a barrel Thursday morning, extending their retreat from this week’s highs as concerns over immediate Middle East supply disruptions eased.

Oil prices came under pressure as Saudi Arabia worked to maintain crude exports following attacks on its East-West pipeline. Saudi shipments are being redirected through Oman’s Sohar port, while expectations that damaged pipeline infrastructure could return to service within days have reduced some of the geopolitical risk premium that recently pushed Brent toward $110. (Reuters)

Prices also reacted to comments from U.S. President Donald Trump expressing hope that the war with Iran was nearing an end, although fighting involving Saudi Arabia and Houthi forces continued to keep regional supply risks elevated. (Internazionale)

Brent nevertheless remains above $100 as Middle East tensions continue to threaten energy flows.

💬

Global Finance News 09-17-26

Brent Crude Surges Above $109 as Saudi Pipeline Shutdown Deepens Supply Fears

Brent crude surged more than 4% on Monday, climbing to $109.33 a barrel as escalating Middle East disruptions intensified concerns over global oil supplies.

The latest rally followed drone attacks that damaged Saudi Arabia’s East-West pipeline, forcing the key route to remain closed over the weekend. The pipeline has become particularly important because it allows Saudi crude to bypass the Strait of Hormuz and reach the Red Sea. Reuters reported that fresh attacks on Saudi energy infrastructure and vessels in the region have compounded supply concerns.

Risks are also increasing around the Bab el-Mandeb shipping route, while a planned meeting between Iran and Gulf states to discuss shipping through the Strait of Hormuz was postponed. The setback reduced hopes for an immediate diplomatic solution to disruptions affecting some of the world’s most important energy corridors.(Reuters)

Brent has now returned to the $109 area after briefly retreating toward $104 late last week. The renewed surge is likely to keep inflation concerns elevated ahead of this week’s Federal Reserve decision, with higher energy costs adding another complication for the interest-rate outlook.

💬

WS Investor 09-14-26

Brent Crude Falls 3% as Diplomatic Hopes Trigger Pullback From Near $110

Brent crude futures fell sharply on Friday, retreating 3.02% to $104.38 a barrel after briefly approaching $110 earlier in the session. The decline follows Thursday’s 6.3% surge, when Brent settled at $107.63 amid escalating attacks on shipping in the Middle East.

The pullback came as traders reacted to reports that Gulf ministers are expected to meet Iran next week in an effort to secure temporary access through the Strait of Hormuz. Any improvement in shipping conditions could ease some of the supply-risk premium that has rapidly built into crude prices. (Financial Times)

Still, supply risks remain elevated. Traffic through Hormuz continues to be constrained, while the Iran-aligned Houthis’ seizure of Yemen’s Mocha port has increased concerns over another critical shipping route near the Bab al-Mandeb Strait.

Despite Friday’s decline, Brent remains on track for a weekly gain of roughly 10% and is set to finish the week above $100 for the first time since mid-May, underscoring how strongly the prolonged Middle East conflict continues to influence global energy markets.

💬

European Investor 09-11-26

Brent Crude Surges Above $105 as Middle East Supply Crisis Deepens

Brent crude oil extended its powerful rally Thursday, climbing 4.28% to $105.54 a barrel as escalating Middle East tensions and severe supply disruptions intensified concerns over global oil availability. Brent has now gained more than 10% over the past five sessions.

A sharp deterioration in Saudi Arabian supply has become a major catalyst. Saudi crude production reportedly fell to around 6.2 million barrels per day in August, down roughly 23% and reaching levels last seen in the 1990s, as regional conflict disrupted exports and shipping routes (Financial Times).

The broader supply picture is also tightening. Flows through the Strait of Hormuz remain severely constrained amid the U.S.-Iran conflict. The disruptions have increased concerns that available supply may struggle to compensate for lost Gulf barrels.

The oil rally is also spilling into global financial markets. U.S. producer inflation accelerated to 5.4% year over year in August, while the 10-year Treasury yield climbed to around 4.92% as investors assessed the risk that higher energy costs could prolong inflation and force the Federal Reserve to maintain tighter monetary policy.

With Brent now firmly above $100, markets are closely watching developments around Hormuz and Saudi production. Further supply disruptions could keep upward pressure on crude prices and reinforce inflation concerns across the global economy.

💬

The Investor 09-10-26

09-30-26WS News

09-23-26WS News

09-22-26WS News

NASDAQ:MRNA

Moderna Stock Falls 6.3% as Citi Downgrades Shares to Sell

Moderna shares fell 6.3% after Citigroup downgraded the biotechnology company to Sell from Neutral while raising its price target to $80 from $60.

Despite the higher target, the Sell rating signals a more cautious overall view on the stock relative to its current price of about $190.64.

More broadly, Moderna remains highly sensitive to expectations around its post-COVID revenue base, the commercial performance of newer vaccines and the timing and probability of success across its pipeline. Elevated research and development spending, continued cash burn and uncertainty around how quickly new products can offset declining legacy vaccine revenue are probable factors behind a more conservative stance.

The sharp decline suggests investors focused primarily on the downgrade and the large gap between the analyst’s $80 target and Moderna’s current share price.

💬

The Investor 09-30-26

Moderna Stock Surges 14% After Wolfe Research Upgrade

Moderna (NASDAQ: MRNA) shares surged about 14.1% on Tuesday after Wolfe Research upgraded the biotechnology company to Peer Perform from Underperform, improving Wall Street sentiment toward the stock.

Analyst Alexandria Hammond's upgrade removes Wolfe Research's bearish rating on Moderna and signals a more balanced assessment of the company's risk-reward profile.

Why Is Moderna Stock Rising?

The upgrade appears to be an important catalyst for Tuesday's sharp move. A shift from Underperform to Peer Perform suggests Wolfe Research no longer expects Moderna to materially lag comparable biotechnology stocks.

Investor attention is also increasingly focused on Moderna's pipeline beyond COVID-19 vaccines, particularly its cancer vaccine program. The company is developing an individualized neoantigen therapy, intismeran autogene (mRNA-4157/V940), with Merck's Keytruda. The program represents one of Moderna's most important opportunities to demonstrate that its mRNA technology can expand successfully into oncology.

Positive progress in cancer vaccines could significantly broaden Moderna's long-term growth profile beyond respiratory vaccines and remains an important component of the investment case surrounding the company.

## Sentiment Improves, but Rating Remains Cautious

The Peer Perform rating is not equivalent to a Buy or Outperform recommendation. Instead, it indicates that Wolfe Research has become less bearish on Moderna.

Still, the 14% rally suggests investors are responding strongly to the removal of the Underperform rating, while Moderna's cancer vaccine opportunity and broader mRNA pipeline continue to provide potentially significant long-term catalysts.

💬

WS Investor 08-25-26

Moderna Soars 100%, Merck Jumps 10% After Landmark Phase 3 Cancer Vaccine Results

Moderna shares surged about 100% on Wednesday, while Merck climbed roughly 10%, after the companies announced positive Phase 3 results for their personalized mRNA cancer therapy intismeran autogene in combination with Merck’s blockbuster immunotherapy KEYTRUDA.

The INTerpath-001 trial met both its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival in patients with completely resected Stage IIB-IV melanoma. The combination produced statistically significant and clinically meaningful improvements compared with KEYTRUDA alone.

A Major Milestone for Moderna’s mRNA Platform

The results are particularly significant for Moderna because they represent the first positive Phase 3 readout for an individualized neoantigen therapy and the first positive Phase 3 study for an mRNA-based cancer therapy. The treatment is individually manufactured using mutations identified from each patient's tumor, with the resulting mRNA therapy designed to train the immune system to recognize and attack cancer cells.

That breakthrough likely explains the much larger reaction in Moderna shares. The results potentially validate the use of Moderna's mRNA technology beyond infectious-disease vaccines and provide important clinical validation for its oncology pipeline.

The companies also said no new safety signals were observed. They plan to present detailed data at an upcoming international medical meeting and share the results with regulatory authorities, opening the path toward potential filing submissions.

Merck Gains as KEYTRUDA Franchise Could Expand

For Merck, the results strengthen the long-term position of KEYTRUDA, its cornerstone cancer therapy. The combination is the first regimen to demonstrate statistically significant and clinically meaningful improvements in both recurrence-free and distant metastasis-free survival compared with KEYTRUDA alone in this adjuvant melanoma population.

Earlier Phase 2b data had already provided encouraging evidence: at five-year follow-up, the combination showed a 49% reduction in the risk of recurrence or death and a 59% reduction in the risk of distant metastasis or death compared with KEYTRUDA alone.

The companies are now studying intismeran across a broader oncology program encompassing nine Phase 2 and Phase 3 trials, including melanoma, non-small cell lung cancer, bladder cancer and renal cell carcinoma.

With Moderna up around 100% and Merck gaining about 10%, the market reaction reflects more than a single successful melanoma trial. Investors appear to be pricing in the possibility that personalized mRNA cancer therapies could become a new treatment platform, with potentially much broader applications if ongoing trials in other tumor types are successful.

💬

Global Finance News 08-19-26

BioNTech and Moderna: Two mRNA Giants Chart Different Paths as COVID Revenue Fades

May 6, 2026 · Earnings Analysis

The two companies that changed the world with their mRNA COVID-19 vaccines are now deep into a painful reinvention. BioNTech and Moderna both reported first quarter 2026 results within days of each other, and while the headline numbers tell a familiar story of declining vaccine revenues and widening losses, a closer look reveals two very different bets on what comes next.

BioNTech posted Q1 revenues of €118.1 million, down from €182.8 million a year ago, with net loss widening to €531.9 million. Moderna reported $389 million in revenue, up significantly from the prior year but heavily supported by international government deliveries. Moderna's net loss of $1.3 billion was inflated by a $0.9 billion one-time litigation charge, making its underlying trajectory somewhat less alarming than the headline implies. BioNTech ended the quarter with €16.8 billion in cash while Moderna held $7.5 billion.

Where the two companies diverge most sharply is strategy. BioNTech has made oncology its singular focus, pouring resources into pumitamig, gotistobart, and a growing antibody-drug conjugate portfolio, with six late-stage data readouts expected in 2026. Moderna is playing a broader game, advancing infectious disease vaccines including the world's first approved flu plus COVID combination product, while also pursuing oncology and rare disease therapeutics. Its personalized cancer vaccine intismeran, developed with Merck, will present five-year melanoma data at ASCO in June.

BioNTech is also navigating a manufacturing restructuring affecting 1,860 jobs and the planned departure of its co-founders by end of 2026. Moderna, by contrast, is cutting costs aggressively, with R&D spending down 24% year-over-year.

Both are burning cash to fund their futures. BioNTech is going deep and narrow on cancer. Moderna is going wide across multiple disease areas. Which approach pays off will likely become clearer before the year is out.

💬

WS Investor 05-06-26

Moderna Shares Fall 3.4% as Earnings Highlight Losses Despite Pipeline Progress

Shares of Moderna, Inc. declined 3.44% to $44.36 on today, as investors reacted to the company’s first-quarter 2026 earnings, which revealed significant losses driven by one-time charges despite improving revenue trends and pipeline developments.

The biotech firm reported quarterly revenue of $389 million, a sharp increase compared to the prior year, largely supported by higher COVID-19 vaccine sales in international markets. Approximately 80% of total revenue came from outside the United States, reflecting the company’s growing global footprint.

However, profitability remained under pressure. Moderna posted a GAAP net loss of $1.3 billion, with a loss per share of $3.40. A major factor behind the loss was a $0.9 billion non-recurring litigation settlement charge, which significantly weighed on earnings during the quarter.

Despite the headline loss, underlying cost discipline showed improvement. Research and development expenses declined 24% year-over-year, while selling, general and administrative expenses fell 18%, indicating ongoing efforts to streamline operations following the pandemic-driven peak period.

On the strategic front, Moderna continued to advance its pipeline. The company secured key regulatory approvals in Europe, including for its flu and COVID combination vaccine, and initiated a Phase 3 trial for a lung cancer treatment. These developments underscore its transition toward a broader portfolio beyond COVID vaccines.

CEO Stéphane Bancel emphasized confidence in returning to revenue growth in 2026, supported by upcoming product launches and continued clinical progress across multiple therapeutic areas.

Looking ahead, Moderna reiterated its expectation of up to 10% revenue growth for full-year 2026, alongside plans to reduce operating expenses excluding the one-time litigation impact. The company also projected year-end cash and investments between $4.5 billion and $5.0 billion, maintaining a solid liquidity position.

Overall, while revenue growth and pipeline momentum provided some positive signals, the substantial quarterly loss and ongoing transition period appear to have weighed on investor sentiment, pushing the stock lower following the earnings release.

💬

European Investor 05-01-26

Recordati and Moderna Partner on mRNA Therapy for Propionic Acidemia

Recordati Industria Chimica e Farmaceutica has entered into a global collaboration and license agreement with Moderna to develop and commercialize mRNA-3927, an investigational therapy for propionic acidemia (PA), a rare inherited metabolic disorder.

Under the agreement, Moderna will continue to lead the clinical development of mRNA-3927, while Recordati will assume responsibility for global commercialization if the therapy receives regulatory approval. The collaboration brings together Moderna’s expertise in mRNA-based therapies and Recordati’s established global rare disease commercial infrastructure.

mRNA-3927 is designed to restore the activity of the propionyl-CoA carboxylase (PCC) enzyme, which is deficient in patients with propionic acidemia. The condition leads to the accumulation of toxic metabolites and can result in recurrent life-threatening metabolic decompensation events, as well as neurological and cardiac complications. Currently, no approved therapies directly target the underlying cause of the disease, and treatment options are largely symptomatic, sometimes including liver transplantation.

Interim clinical data published in Nature showed early signs of clinical improvement. The therapy is currently being evaluated in a potential registrational study aimed at reducing metabolic decompensation events, with patient enrollment completed and a data readout expected by the end of 2026.

Financial terms of the agreement include a $50 million upfront payment from Recordati to Moderna, along with up to $110 million in near-term development and regulatory milestones. Moderna is also eligible for additional commercial and sales milestones, as well as tiered royalties on annual net sales. Recordati indicated that it does not expect a significant EBITDA impact prior to a potential launch. The transaction remains subject to customary closing conditions, including U.S. antitrust clearance.

Propionic acidemia affects approximately 1 in 100,000 to 150,000 individuals worldwide and is caused by pathogenic variants in the PCCA or PCCB genes, resulting in PCC deficiency.

💬

Global Finance News 02-18-26

Moderna said it expects 2025 revenue of about $1.9 billion on an unaudited basis, roughly $100 million above the midpoint of the range it discussed on its third-quarter 2025 earnings call, as the company provided business and pipeline updates at the 44th Annual J.P. Morgan Healthcare Conference. Moderna also said it improved its expected 2025 GAAP operating expenses by $200 million versus its prior outlook, and raised its projected year-end 2025 cash balance to about $8.1 billion, including a $0.6 billion draw from its recently announced $1.5 billion term loan facility.

Looking ahead, Moderna reiterated its plan for up to 10% revenue growth in 2026 alongside further GAAP operating expense reductions, with 2026 GAAP operating expenses expected to be about $4.9 billion. The company also pointed to multiple potential 2026 catalysts, including possible first approvals for its seasonal flu vaccine and flu/COVID combination vaccine, and pivotal trial readouts across oncology, rare disease, and infectious disease programs.

Source: Accesswire

💬

The Investor 01-12-26

Moderna said it made meaningful operational, commercial and pipeline progress in 2025 despite a challenging U.S. market, according to a shareholder letter released on January 5. The company reported having three approved commercial products, improved demand forecasting in an endemic environment, and cost reductions that exceeded its original cash cost reduction target by nearly $1 billion. Moderna said disciplined execution across manufacturing, R&D and SG&A helped lower GAAP operating expenses to an expected level below $5.5 billion in 2025, down sharply from prior years.

Commercially, Moderna highlighted the U.S. launch of its updated COVID vaccine mNEXSPIKE as a key driver, noting it accounted for about 24 percent of U.S. retail COVID vaccinations in 2025 and nearly one-third of doses among adults aged 65 and older. The company also pointed to multi-year partnerships in markets such as the UK, Canada and Australia, along with new agreements in Brazil and Taiwan, as providing revenue visibility and strengthening its global manufacturing footprint.

Looking ahead, Moderna said it expects to return to revenue growth in 2026, targeting up to 10 percent growth, supported by its seasonal vaccine franchise and geographic expansion. The company reiterated its goal of reaching cash breakeven in 2028 and outlined longer-term growth opportunities in oncology and rare diseases, including late-stage programs such as intismeran autogene and mRNA-based therapies for propionic acidemia and methylmalonic acidemia.

💬

European Investor 01-05-26

Moderna Q3 2025 Results: Narrowed Guidance, Cost Cuts, and Pipeline Progress

Moderna reported third-quarter 2025 revenue of $1.0 billion, down 45% year over year, driven by lower COVID-19 vaccine sales. The company posted a GAAP net loss of $200 million, or $0.51 per share, compared with a $13 million profit in Q3 2024.

COVID-19 vaccines contributed $971 million in sales during the quarter, including $781 million from the U.S. and $190 million from international markets. Moderna’s new mNEXSPIKE vaccine, approved in 40 countries, has seen strong uptake among higher-risk adults. The RSV vaccine mRESVIA generated $2 million in sales.

Cost of sales fell 60% to $207 million, while R&D expenses dropped 30% to $801 million as cost-cutting and trial prioritization continued. SG&A expenses declined 5% to $268 million. The company ended the quarter with $6.6 billion in cash and investments, expecting a year-end balance of $6.5–$7.0 billion, up from prior estimates.

Moderna narrowed its 2025 revenue outlook to $1.6–$2.0 billion (previously $1.5–$2.2 billion) and lowered expected GAAP operating expenses by $0.7 billion to $5.2–$5.4 billion. It also improved its cash outlook by $0.5–$1 billion, citing cost efficiencies.

Pipeline progress included Phase 3 results for the flu vaccine (mRNA-1010) and the combined flu/COVID vaccine (mRNA-1083), with global filings expected by early 2026. In oncology, Moderna and Merck’s personalized cancer vaccine mRNA-4157 is in multiple Phase 3 and Phase 2 trials. The company is advancing treatments for rare metabolic diseases such as propionic acidemia (mRNA-3927) and methylmalonic acidemia (mRNA-3705), with the latter entering a registrational study in 2026.

CEO Stéphane Bancel said the company achieved “strong commercial and financial performance” amid its cost-reduction program and remains focused on financial discipline as it expands its mRNA-based portfolio.

💬

The Investor 11-06-25

Moderna Announces Results of 2025 Annual Meeting of Stockholders

On April 30, 2025, Moderna held its 2025 Annual Meeting of Stockholders, where all proposals were approved with a quorum present.

Three directors—Noubar Afeyan, Stéphane Bancel, and François Nader—were re-elected to serve three-year terms expiring in 2028. Stéphane Bancel received the most support, with over 245 million votes in favor.

Shareholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with approximately 192 million votes in favor and 56 million against.

Additionally, Ernst & Young LLP was ratified as Moderna’s independent public accounting firm for 2025, receiving nearly 291 million votes in support.

💬

Global Finance News 05-06-25

09-30-26WS News

08-20-26WS Investor

08-19-26WS News

05-11-26Global Finance News

01-22-26WS News

NYSE:F

💬

WS Investor 09-29-26

Ford U.S. Sales Fall 10.3% in August as EV Demand Plunges Nearly 80%

Ford Motor Company reported a sharp decline in U.S. vehicle sales in August 2026, with total sales falling 10.3% year over year to 170,681 vehicles from 190,206 a year earlier. Year-to-date sales reached 1.35 million vehicles, down 9.8% from the same period in 2025.

The biggest weakness came from Ford’s electrified portfolio. Total electrified vehicle sales dropped 41.5% to 17,237 units in August, while fully electric vehicle sales plunged 79.4% to just 2,197 units from 10,671 a year earlier. Hybrid sales were also under pressure, falling 19.9% to 15,040 vehicles. Year to date, EV sales are down 64%, while hybrid sales have declined 20.4%.

Internal-combustion vehicles performed considerably better but still recorded a decline. Ford sold 153,444 gasoline and diesel vehicles during August, down 4.6% year over year. That helped cushion the much steeper contraction in electrified vehicles.

By vehicle category, SUVs were the main source of weakness, with sales falling 23.3% to 62,538 units. Truck sales proved significantly more resilient, slipping just 0.9% to 104,496 vehicles and accounting for roughly 61% of Ford’s total August sales. Cars were the only category to record growth, rising 12.7% to 3,647 units, although they remain a relatively small part of Ford’s overall business.

The August figures highlight a difficult sales environment for Ford, particularly within its electric vehicle portfolio. The nearly 80% collapse in monthly EV sales stands out as the most significant weakness, while relatively stable truck demand provided an important offset. With total year-to-date sales down 9.8%, Ford will need stronger performance in the remaining months of 2026 to narrow its full-year decline.

💬

The Investor 09-02-26

Ford Stock Rises 5% in Premarket as Higher Full-Year Guidance Overshadows Quarterly Loss

Ford Motor (NYSE: F) shares climbed 5% in Wednesday's premarket trading after the automaker raised its full-year earnings and free cash flow guidance, with investors looking past a reported quarterly net loss that was largely driven by one-time charges.

Ford reported second-quarter revenue of $48.3 billion, down 4% from a year earlier due to lower wholesale volumes, discontinued products, aluminum supply constraints, and lower production of first-generation electric vehicles. The company posted a net loss of $1.3 billion, or $0.33 per share, primarily because of a $3.6 billion largely non-cash charge related to the previously announced disposition of the BlueOval SK joint venture, along with charges tied to canceled EV programs.

Excluding these one-time items, underlying performance improved. Adjusted EBIT rose to $2.5 billion from $2.1 billion a year earlier, while adjusted EPS increased to $0.42 from $0.37. Adjusted EBIT margin also expanded to 5.2% from 4.3%, reflecting stronger profitability and improved operating discipline.

The biggest catalyst for the stock was Ford's upgraded full-year outlook. The company raised its 2026 adjusted EBIT guidance to $10.0 billion-$11.0 billion from the previous range of $8.5 billion-$10.5 billion. It also lifted adjusted free cash flow guidance to $6.0 billion-$7.0 billion from $5.0 billion-$6.0 billion, signaling growing confidence in the business despite ongoing macroeconomic uncertainty.

Management highlighted strong pricing power for its truck, off-road, and hybrid vehicle lineup, improving product quality, and expanding higher-margin businesses such as Ford Energy. The company also generated $4.3 billion in operating cash flow during the quarter, ended the period with $22.3 billion in cash and $43.4 billion in liquidity, and declared a quarterly dividend of $0.15 per share.

The strong premarket rally reflects investors' focus on Ford's improving underlying profitability and significantly higher full-year guidance rather than the headline net loss, which was largely attributable to non-cash accounting charges. The results reinforce management's view that operational improvements and disciplined cost management are beginning to translate into stronger earnings power.

💬

Global Finance News 07-29-26

Ford Surges 13% as Morgan Stanley Calls It an AI Energy Stock

May 13, 2026 | NYSE: F

Ford is one of today's most talked-about names on Wall Street, with shares surging as much as 13% — and the reason has nothing to do with trucks.

Ford soared on Morgan Stanley's positive comments about its energy business. The bank noted that Ford recently secured a license from China's CATL, the world's largest battery manufacturer, giving it the right to produce batteries in the US — not for electric cars, but for energy storage systems targeting large commercial customers and potentially AI hyperscalers. (The Motley Fool)

Morgan Stanley's analyst described Ford's CATL tie-up as "an underappreciated strategic competitive advantage," estimating Ford Energy could generate $500 million to $600 million in run-rate annual EBIT from 20 gigawatt-hours of output. (ts2*tech)

Ford plans to invest approximately $2 billion to scale the business, targeting annual deployments of at least 20 GWh by 2027, with systems assembled in Kentucky. The move followed a reported $19.5 billion cumulative loss in Ford's EV division, prompting a strategic shift toward repurposing underutilized EV battery manufacturing capacity for the energy storage market — supplying utilities, data centers, and heavy industry instead. (StockStory / FinancialContent)

The energy pivot lands on top of an already strong earnings backdrop. Ford's Q1 delivered $43.3 billion in revenue, adjusted EPS of $0.66 that crushed the $0.19 consensus estimate, and a raised full-year EBIT guidance range of $8.5 to $10.5 billion. Ford Pro, the commercial vehicle segment, contributed $1.69 billion in EBIT with paid software subscriptions up 30% to 879,000.

Morgan Stanley is penciling in Ford Energy announcing one or more large customer deals "over the next few months," and points to Tesla's energy business — which generates profit margins twice as high as its car business — as a potential reference point for what Ford could build. (The Motley Fool)

For a stock that was down 9% year to date, today's move represents a meaningful narrative shift — from struggling EV laggard to potential AI infrastructure play.

💬

The Investor 05-13-26

Ford Motor Company reported strong first-quarter 2026 results and raised its full-year guidance, supported by favorable pricing, product mix, and software-driven revenue.

Revenue reached $43.3 billion, while net income came in at $2.5 billion and adjusted EBIT totaled $3.5 billion. The results included a $1.3 billion one-time tariff-related benefit, which boosted profitability during the quarter.

Operating cash flow was $1.3 billion, though adjusted free cash flow showed a use of $1.9 billion. The company also declared a quarterly dividend of $0.15 per share.

Looking ahead, Ford raised its full-year adjusted EBIT guidance to a range of $8.5–$10.5 billion, up from the previous $8.0–$10.0 billion outlook, reflecting confidence in ongoing execution and cost improvements.

Management highlighted continued progress in its Ford+ strategy, focusing on higher-margin products, software and services growth, and improving electric vehicle profitability.

Source: Company press release

💬

Global Finance News 04-30-26

Dearborn, Mich., April 15, 2026 — Ford Motor Company announced the creation of a new Product Creation and Industrialization organization aimed at accelerating the development and scaling of next-generation vehicles and technologies.

The new unit integrates Ford’s electric vehicle, digital, design, and global industrial teams into a single structure, with the goal of speeding up decision-making, reducing complexity, and supporting the company’s Ford+ strategy, including a target of achieving an 8% adjusted EBIT margin by 2029.

Ford plans a major product renewal, aiming to refresh 80% of its North American portfolio and 70% of its global lineup by volume by 2029, alongside expanding electrification across nearly 90% of its nameplates by 2030. The initiative also supports the rollout of software-defined vehicles, over-the-air updates, and advanced driver assistance technologies.

The restructuring comes with leadership changes, including the departure of Chief EV and Digital Officer Doug Field, while COO Kumar Galhotra will lead the new organization.

Ford said the move positions the company to scale digital innovation, electrification, and manufacturing efficiency as it transitions toward a more software-driven automotive future.

💬

WS Investor 04-16-26

Ford Motor Company reported a higher U.S. retail market share in Q1 2026, supported by strong demand for trucks and large SUVs despite an overall decline in total sales.

Ford’s retail share rose to 11.6%, up 0.2 percentage points, driven by double-digit growth in high-margin SUV models such as Explorer and Expedition. Combined sales of key SUVs increased 17.9%, while Expedition sales jumped 30.2% and Explorer rose nearly 30%.

The Ford F-Series maintained its position as America’s best-selling truck, with 159,901 units sold, reinforcing Ford’s long-standing leadership in the segment. Total pickup and van sales reached 257,475 vehicles, while the Ford Transit remained the top-selling van.

However, total vehicle sales declined 8.8% year-over-year, reflecting product transitions and tough comparisons with a strong prior-year period. Ford said it is focusing on a more profitable product mix, emphasizing SUVs, trucks, and commercial vehicles.

The company also highlighted growth in its software and technology segment, with Ford Pro subscriptions rising about 29% to over 865,000, and its BlueCruise hands-free driving system surpassing 10 million cumulative usage hours.

💬

The Investor 04-03-26

Tesla Model Y outsells everything in three states, but Ford dominates

The Tesla Model Y was the best-selling vehicle in three different states in the U.S. last year, according to new data that shows the all-electric crossover outsold every other car in a few places.

(teslarati.com)

💬

WS Investor 03-09-26

Ford Motor Company reported fourth-quarter and full-year 2025 results marked by revenue growth but significant GAAP losses tied to special items.

Fourth-quarter revenue was $45.9 billion, contributing to full-year revenue of $187.3 billion, the company’s fifth consecutive year of annual growth. However, Ford posted a net loss of $11.1 billion in Q4 and $8.2 billion for the full year, reflecting the impact of special items. On an adjusted basis, fourth-quarter EBIT was $1.0 billion and full-year adjusted EBIT totaled $6.8 billion.

For 2025, operating cash flow reached $21.3 billion, while adjusted free cash flow was $3.5 billion.

Looking ahead to 2026, Ford expects adjusted EBIT of $8.0 billion to $10.0 billion and adjusted free cash flow of $5.0 billion to $6.0 billion. Capital expenditures are projected between $9.5 billion and $10.5 billion.

Management highlighted ongoing efforts to improve quality, reduce material and warranty costs, enhance EV profitability, and strengthen capital discipline as key drivers for margin expansion toward its 8% adjusted EBIT margin target by 2029.

Source: Company press release (Feb. 10, 2026).

💬

WS Investor 02-11-26

Ford Q4 earnings preview: EV losses, F-150 pickup business crucial for investors

Big Three automaker Ford is on deck to report fourth quarter results Tuesday after the bell, with particular focus on its EV business and the effects of an aluminum plant fire that impacted Ford’s franchise F-150 sales.

(finance.yahoo.com)

💬

WS News 02-10-26

07-29-26The Investor

06-26-26Global Finance News

06-14-26Global Finance News

05-14-26WS Investor

NYSE:KVUE

Kenvue Highlights New Neutrogena, Aveeno and Regaine Research at EADV 2026

Kenvue announced that its Neutrogena, Aveeno and Regaine brands will present 12 new scientific data sets at the 2026 European Academy of Dermatology and Venereology Congress, covering skin barrier health, acne, hyperpigmentation, eczema, UV-related damage and hair loss.

Neutrogena research highlighted multifunctional sunscreens containing ingredients such as niacinamide and trehalose. One study reported reductions in visible redness, acne-related hyperpigmentation, skin oiliness and shine, while another showed improved hydration, skin tone uniformity and reductions in visible facial spots.

Aveeno studies focused on colloidal oat formulations. Research found support for skin barrier proteins, hydration and ceramide production following UV exposure. A separate international clinician survey also highlighted the use of colloidal oat-based emollients alongside topical corticosteroids in eczema care.

Regaine research examined 5% minoxidil in male androgenetic alopecia. A post-hoc analysis found greater hair regrowth among younger men and patients at earlier stages of hair loss, while improvements versus placebo were observed across all hair-loss classifications studied.

The findings support Kenvue’s broader effort to strengthen its consumer health portfolio with clinically backed research across skin and hair care.

💬

The Investor 09-30-26

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock. The quarterly dividend is payable on October 2, 2026, to shareholders of record as of the close of business on September 21, 2026.

💬

The Investor 09-10-26

Kenvue Edges Up 1% as Margin Gains and Kimberly-Clark Deal Progress Steady the Ship

Summit, N.J., May 7, 2026 — Shares in Kenvue rose a modest 1% today after the consumer health company reported first quarter results that showed meaningful progress on profitability, even as organic sales growth remained thin and the business continues to operate in the shadow of its pending acquisition by Kimberly-Clark.

Net sales grew 4.5% to start the year, but the headline figure was heavily flattered by a 3.8% foreign currency tailwind. Organic sales growth — the more honest measure of underlying demand — came in at just 0.7%, driven by 1% favorable pricing partially offset by a 0.3% volume decline. For a company anchored in household staples like Tylenol, Neutrogena, and Listerine, that is a modest performance, though management framed it as a second consecutive quarter of organic growth after a difficult stretch.

Where the report genuinely impressed was on margins. Adjusted gross profit margin expanded 80 basis points to 60.8%, and adjusted operating income margin widened a full 420 basis points to 24.0%, reflecting the benefits of supply chain optimization, cost reduction initiatives, and lower SGA spending. Adjusted diluted EPS of $0.32 was up 33% year-over-year, a meaningful improvement driven more by cost discipline than revenue momentum. Free cash flow also nearly doubled to $0.4 billion.

The segment picture was mixed. Skin Health and Beauty was the standout, with 5% organic growth fueled by Neutrogena internationally and strong eCommerce execution. Essential Health added 1.5% organically. Self Care was the drag, with organic sales falling 2.3% as weak cold and flu seasons across major markets weighed on demand, partially offset by share gains in smoking cessation and sequential improvement for Tylenol.

With the Kimberly-Clark acquisition expected to close in the second half of 2026 and all shareholder and U.S. antitrust approvals already secured, Kenvue is not providing forward-looking guidance. The stock's quiet gain reflects a market content to wait for the deal to close rather than reprice the business on its own merits.

💬

European Investor 05-07-26

Kenvue Inc. (NYSE: KVUE) declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as of the close of business on May 13, 2026.

💬

Global Finance News 04-30-26

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

💬

The Investor 04-24-26

Kenvue Inc. (NYSE: KVUE) reported improved fourth-quarter performance but lower full-year sales for 2025.

Fourth-quarter net sales rose 3.2%, driven by 1.2% organic growth and a 2.1% FX benefit. Diluted EPS was $0.17, with adjusted EPS of $0.27. Gross margin was flat at 56.5%, while adjusted operating margin improved to 19.9%. Growth was led by Essential Health (+6.1%) and Skin Health and Beauty (+2.9%), while Self Care rose 1.5%.

For full-year 2025, net sales declined 2.1%, with organic sales down 2.2% due to lower volumes. Diluted EPS was $0.76 and adjusted EPS was $1.08. Free cash flow increased to $1.7 billion, and total debt stood at $8.5 billion at year-end.

Due to its pending merger with Kimberly-Clark, expected to close in the second half of 2026, Kenvue will not provide forward guidance.

Source: Business Wire

💬

Global Finance News 02-18-26

Kimberly-Clark Corporation and Kenvue Inc. announced that shareholders of both companies have overwhelmingly approved all proposals required for Kimberly-Clark’s acquisition of Kenvue, marking a key milestone in the creation of a global health and wellness leader. The approvals were obtained at separate special shareholder meetings held on January 29, 2026.

Based on preliminary results, around 96 percent of the shares present at Kimberly-Clark’s special meeting voted in favor of issuing Kimberly-Clark shares for the transaction, while approximately 99 percent of the shares voted at Kenvue’s meeting approved the merger agreement, representing about 77 percent of Kenvue’s total outstanding shares. Final voting results will be formally filed with the U.S. Securities and Exchange Commission.

Company executives from both sides highlighted the strategic rationale of the deal, emphasizing expanded growth opportunities, accelerated innovation, and the ability to broaden access to trusted consumer health and personal care brands worldwide. The transaction is expected to close in the second half of 2026, subject to regulatory approvals and customary closing conditions.

Source: PR Newswire

💬

The Investor 01-29-26

Kenvue Inc. (NYSE: KVUE) declared a quarterly dividend of $0.2075 per share on its common stock. Dividend is payable on February 25, 2026, to shareholders of record as of the close of business on February 11, 2026.

💬

WS Investor 01-28-26

Kimberly-Clark to Acquire Kenvue in $3.50 Cash and Stock Deal

Kenvue (NYSE: KVUE) entered into a definitive merger agreement to be acquired by Kimberly-Clark (NYSE: KMB). Under the deal, Kenvue shareholders will receive 0.14625 shares of Kimberly-Clark common stock and $3.50 in cash per Kenvue share. The transaction, unanimously approved by both boards, will create a combined company with expanded consumer health and hygiene portfolios. Following the merger, Kenvue will become a wholly owned subsidiary of Kimberly-Clark through a two-step merger structure. Kenvue CEO Kirk Perry, previously interim CEO, was appointed permanently alongside an amended executive severance plan effective at closing. The companies expect to file a joint proxy statement and Form S-4 registration with the SEC, with closing targeted following regulatory and shareholder approvals.

💬

Global Finance News 11-03-25

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on November 26, 2025, to shareholders of record as of the close of business on November 12, 2025.

💬

The Investor 10-29-25

11-03-25Global Finance News

10-07-25WS News

10-06-25European Investor

09-23-25The Investor

04-08-25WS Investor

Latest

Progress Software Stock Falls 3% Despite Higher Earnings and Raised Revenue Outlook Progress Software shares fell 3% after the company

Micron Stock Rises around 1% After Record Q4 Revenue and Strong Fiscal 2027 Guidance Micron shares rose around 1% after

Phillips 66 Stock Rises 2.9% as Goldman Sachs and TD Cowen Raise Price Targets Phillips 66 shares rose 2.9% after

Moderna Stock Falls 6.3% as Citi Downgrades Shares to Sell Moderna shares fell 6.3% after Citigroup downgraded the biotechnology company

FormFactor Stock Jumps 8.3% as Deutsche Bank Initiates Coverage With Buy Rating FormFactor shares jumped 8.3% after Deutsche Bank initiated

Equifax Stock Falls 2.1% as BMO Capital Cuts Price Target to $160 Equifax shares fell 2.1% after BMO Capital Markets

The Hartford Names A. Morris Tooker as Next CEO The Hartford announced that company President A. Morris “Mo” Tooker will

Servier Adopts Veeva OpenData Across More Than 80 Countries to Support AI Expansion Veeva Systems announced that French pharmaceutical company

General Mills Names Dana McNabb as CEO Effective January 2027 General Mills announced that its board has unanimously elected Chief

Kenvue Highlights New Neutrogena, Aveeno and Regaine Research at EADV 2026 Kenvue announced that its Neutrogena, Aveeno and Regaine brands

FIS to Modernize Kredittbanken’s Core Platform With PRIME in the Cloud FIS announced that Norwegian consumer credit institution Kredittbanken has

Trane Technologies Demonstrates 800-Volt DC Chiller for AI Data Centers Trane Technologies said it successfully demonstrated what it describes as

GermanyFollow

USFollow

10-year Treasury yield hits highest level since 2007 as market prices in another Fed rate hike

NASDAQ:MUFollow

Tech stocks live: Micron stock jumps over 12% on earnings beat after tumbling earlier this week

GoldFollow

Gold steadies above $4,300 as oil eases and yields stay high - Kitco AM Report | Kitco News

Gold price holding near session highs as US pending home sales rise 0.3% | Kitco News

The next trillion matters more for gold than the next Fed rate hike | Kitco News

NYSE:JPMFollow

NYSE:BAFollow

Brent CrudeFollow

NASDAQ:MRNAFollow

NYSE:FFollow

Tesla Model Y outsells everything in three states, but Ford dominates

Ford Q4 earnings preview: EV losses, F-150 pickup business crucial for investors

NYSE:KVUEFollow

Germany

US

NASDAQ:MU

Gold

NYSE:JPM

NYSE:BA

Brent Crude

NASDAQ:MRNA

NYSE:F

NYSE:KVUE